{"id": "2508.14902", "pdf": "https://arxiv.org/pdf/2508.14902", "abs": "https://arxiv.org/abs/2508.14902", "authors": ["Lennart H. Bosch", "Pernille R. Jensen", "Nico Striegler", "Thomas Unden", "Jochen Scharpf", "Usman Qureshi", "Philipp Neumann", "Martin Gierse", "John W. Blanchard", "Stephan Knecht", "Jochen Scheuer", "Ilai Schwart", "Martin B. Plenio"], "title": "Hierarchical Maximum Likelihood Estimation for Time-Resolved NMR Data", "categories": ["q-bio.QM", "physics.data-an"], "comment": "15 pages, 4 figures", "summary": "Metabolic monitoring and reaction rate estimation using hyperpolarized NMR\ntechnology requires accurate quantitative analysis of multidimensional data\nscenarios. Currently, this analysis is often performed in a two-stage\nprocedure, which is prone to errors in uncertainty propagation and estimation.\nWe propose an approach derived from a Bayesian hierarchical model that\nintrinsically propagates uncertainties and operates on the full data to\nmaximize the precision at minimal uncertainty. In an analytic treatment, we\nreduce the estimation procedure to a least-squares optimization problem which\ncan be understood as an extension of the Variable Projection (VarPro) approach\nfor data scenarios with two predictors. We investigate the method's efficacy in\ntwo experiments with hyperpolarized metabolites recorded with conventional\nhigh-field NMR devices and a micronscale NMR setup using Nitrogen-Vacancy\ncenters in diamond for detection, respectively. In both examples, the new\napproach improves estimates compared to Fourier methods and proves operational\nadvantages over a two-stage procedure employing VarPro. While the approach\npresented is motivated by NMR analysis, it is straightforwardly applicable to\nfurther estimation scenarios with similar data structure, such as time-resolved\nphotospectroscopy.", "AI": {"tldr": "\u672c\u6587\u63d0\u51fa\u4e86\u4e00\u79cd\u57fa\u4e8e\u8d1d\u53f6\u65af\u5206\u5c42\u6a21\u578b\u7684\u6838\u78c1\u5171\u632f\u6570\u636e\u5206\u6790\u65b9\u6cd5\uff0c\u8be5\u65b9\u6cd5\u80fd\u591f\u66f4\u51c6\u786e\u5730\u8fdb\u884c\u4ee3\u8c22\u76d1\u6d4b\u548c\u53cd\u5e94\u901f\u7387\u4f30\u8ba1\u3002", "motivation": "\u4f7f\u7528\u8d85\u6781\u5316\u6838\u78c1\u5171\u632f\u6280\u672f\u8fdb\u884c\u4ee3\u8c22\u76d1\u6d4b\u548c\u53cd\u5e94\u901f\u7387\u4f30\u8ba1\u9700\u8981\u5bf9\u591a\u7ef4\u6570\u636e\u573a\u666f\u8fdb\u884c\u51c6\u786e\u7684\u5b9a\u91cf\u5206\u6790\u3002\u76ee\u524d\uff0c\u8fd9\u79cd\u5206\u6790\u901a\u5e38\u5728\u4e24\u9636\u6bb5\u7a0b\u5e8f\u4e2d\u6267\u884c\uff0c\u5bb9\u6613\u51fa\u73b0\u4e0d\u786e\u5b9a\u6027\u4f20\u64ad\u548c\u4f30\u8ba1\u9519\u8bef\u3002", "method": "\u6211\u4eec\u63d0\u51fa\u4e86\u4e00\u79cd\u6e90\u81ea\u8d1d\u53f6\u65af\u5206\u5c42\u6a21\u578b\u7684\u65b9\u6cd5\uff0c\u8be5\u6a21\u578b\u672c\u8d28\u4e0a\u4f20\u64ad\u4e0d\u786e\u5b9a\u6027\u5e76\u5728\u5b8c\u6574\u6570\u636e\u4e0a\u8fd0\u884c\uff0c\u4ee5\u6700\u5927\u9650\u5ea6\u5730\u63d0\u9ad8\u6700\u5c0f\u4e0d\u786e\u5b9a\u6027\u7684\u7cbe\u5ea6\u3002\u5728\u5206\u6790\u5904\u7406\u4e2d\uff0c\u6211\u4eec\u5c06\u4f30\u8ba1\u7a0b\u5e8f\u7b80\u5316\u4e3a\u6700\u5c0f\u4e8c\u4e58\u4f18\u5316\u95ee\u9898\uff0c\u53ef\u4ee5\u7406\u89e3\u4e3a\u5177\u6709\u4e24\u4e2a\u9884\u6d4b\u53d8\u91cf\u7684\u6570\u636e\u573a\u666f\u7684\u53d8\u91cf\u6295\u5f71 (VarPro) \u65b9\u6cd5\u7684\u6269\u5c55\u3002", "result": "\u5728\u4e24\u4e2a\u4f8b\u5b50\u4e2d\uff0c\u4e0e\u5085\u91cc\u53f6\u65b9\u6cd5\u76f8\u6bd4\uff0c\u65b0\u65b9\u6cd5\u6539\u8fdb\u4e86\u4f30\u8ba1\uff0c\u5e76\u8bc1\u660e\u4e86\u4f18\u4e8e\u91c7\u7528 VarPro \u7684\u4e24\u9636\u6bb5\u7a0b\u5e8f\u7684\u64cd\u4f5c\u4f18\u52bf\u3002", "conclusion": "\u8be5\u65b9\u6cd5\u5728\u4e24\u4e2a\u4f7f\u7528\u9ad8\u573a\u6838\u78c1\u5171\u632f\u8bbe\u5907\u548c\u91d1\u521a\u77f3\u6c2e-\u7a7a\u4f4d\u4e2d\u5fc3\u5fae\u7c73\u7ea7\u6838\u78c1\u5171\u632f\u88c5\u7f6e\u8bb0\u5f55\u7684\u8d85\u6781\u5316\u4ee3\u8c22\u7269\u5b9e\u9a8c\u4e2d\uff0c\u6539\u8fdb\u4e86\u4f30\u8ba1\uff0c\u5e76\u8bc1\u660e\u4e86\u4f18\u4e8e\u4f7f\u7528 VarPro \u7684\u4e24\u9636\u6bb5\u7a0b\u5e8f\u7684\u4f18\u52bf\u3002", "summary_zh": "\u4f7f\u7528\u8d85\u6781\u5316\u6838\u78c1\u5171\u632f\u6280\u672f\u8fdb\u884c\u4ee3\u8c22\u76d1\u6d4b\u548c\u53cd\u5e94\u901f\u7387\u4f30\u8ba1\u9700\u8981\u5bf9\u591a\u7ef4\u6570\u636e\u573a\u666f\u8fdb\u884c\u51c6\u786e\u7684\u5b9a\u91cf\u5206\u6790\u3002\u76ee\u524d\uff0c\u8fd9\u79cd\u5206\u6790\u901a\u5e38\u5728\u4e24\u9636\u6bb5\u7a0b\u5e8f\u4e2d\u6267\u884c\uff0c\u5bb9\u6613\u51fa\u73b0\u4e0d\u786e\u5b9a\u6027\u4f20\u64ad\u548c\u4f30\u8ba1\u9519\u8bef\u3002\u6211\u4eec\u63d0\u51fa\u4e86\u4e00\u79cd\u6e90\u81ea\u8d1d\u53f6\u65af\u5206\u5c42\u6a21\u578b\u7684\u65b9\u6cd5\uff0c\u8be5\u6a21\u578b\u672c\u8d28\u4e0a\u4f20\u64ad\u4e0d\u786e\u5b9a\u6027\u5e76\u5728\u5b8c\u6574\u6570\u636e\u4e0a\u8fd0\u884c\uff0c\u4ee5\u6700\u5927\u9650\u5ea6\u5730\u63d0\u9ad8\u6700\u5c0f\u4e0d\u786e\u5b9a\u6027\u7684\u7cbe\u5ea6\u3002\u5728\u5206\u6790\u5904\u7406\u4e2d\uff0c\u6211\u4eec\u5c06\u4f30\u8ba1\u7a0b\u5e8f\u7b80\u5316\u4e3a\u6700\u5c0f\u4e8c\u4e58\u4f18\u5316\u95ee\u9898\uff0c\u53ef\u4ee5\u7406\u89e3\u4e3a\u5177\u6709\u4e24\u4e2a\u9884\u6d4b\u53d8\u91cf\u7684\u6570\u636e\u573a\u666f\u7684\u53d8\u91cf\u6295\u5f71 (VarPro) \u65b9\u6cd5\u7684\u6269\u5c55\u3002\u6211\u4eec\u7814\u7a76\u4e86\u8be5\u65b9\u6cd5\u5728\u4f7f\u7528\u4f20\u7edf\u9ad8\u573a\u6838\u78c1\u5171\u632f\u8bbe\u5907\u548c\u4f7f\u7528\u91d1\u521a\u77f3\u6c2e-\u7a7a\u4f4d\u4e2d\u5fc3\u5fae\u7c73\u7ea7\u6838\u78c1\u5171\u632f\u88c5\u7f6e\u8bb0\u5f55\u7684\u8d85\u6781\u5316\u4ee3\u8c22\u7269\u7684\u4e24\u4e2a\u5b9e\u9a8c\u4e2d\u7684\u6709\u6548\u6027\u3002\u5728\u4e24\u4e2a\u4f8b\u5b50\u4e2d\uff0c\u4e0e\u5085\u91cc\u53f6\u65b9\u6cd5\u76f8\u6bd4\uff0c\u65b0\u65b9\u6cd5\u6539\u8fdb\u4e86\u4f30\u8ba1\uff0c\u5e76\u8bc1\u660e\u4e86\u4f18\u4e8e\u91c7\u7528 VarPro \u7684\u4e24\u9636\u6bb5\u7a0b\u5e8f\u7684\u64cd\u4f5c\u4f18\u52bf\u3002\u867d\u7136\u6240\u63d0\u51fa\u7684\u65b9\u6cd5\u662f\u7531\u6838\u78c1\u5171\u632f\u5206\u6790\u9a71\u52a8\u7684\uff0c\u4f46\u5b83\u53ef\u4ee5\u76f4\u63a5\u5e94\u7528\u4e8e\u5177\u6709\u7c7b\u4f3c\u6570\u636e\u7ed3\u6784\u7684\u8fdb\u4e00\u6b65\u4f30\u8ba1\u573a\u666f\uff0c\u4f8b\u5982\u65f6\u95f4\u5206\u8fa8\u5149\u5149\u8c31\u5b66\u3002"}}
{"id": "2508.14922", "pdf": "https://arxiv.org/pdf/2508.14922", "abs": "https://arxiv.org/abs/2508.14922", "authors": ["Swati Sharma", "Thanadet Chuangsuwanich", "Royston K. Y. Tan", "Shimna C. Prasad", "Tin A. Tun", "Shamira A. Perera", "Martin L. Buist", "Tin Aung", "Monisha E. Nongpiur", "Micha\u00ebl J. A. Girard"], "title": "Fusing Structural Phenotypes with Functional Data for Early Prediction of Primary Angle Closure Glaucoma Progression", "categories": ["q-bio.QM", "cs.AI", "cs.CV", "eess.IV"], "comment": "23 pages, 5 figures, 3 tables", "summary": "Purpose: To classify eyes as slow or fast glaucoma progressors in patients\nwith primary angle closure glaucoma (PACG) using an integrated approach\ncombining optic nerve head (ONH) structural features and sector-based visual\nfield (VF) functional parameters. Methods: PACG patients with >5 reliable VF\ntests over >5 years were included. Progression was assessed in Zeiss Forum,\nwith baseline VF within six months of OCT. Fast progression was VFI decline\n<-2.0% per year; slow progression >-2.0% per year. OCT volumes were\nAI-segmented to extract 31 ONH parameters. The Glaucoma Hemifield Test defined\nfive regions per hemifield, aligned with RNFL distribution. Mean sensitivity\nper region was combined with structural parameters to train ML classifiers.\nMultiple models were tested, and SHAP identified key predictors. Main outcome\nmeasures: Classification of slow versus fast progressors using combined\nstructural and functional data. Results: We analyzed 451 eyes from 299\npatients. Mean VFI progression was -0.92% per year; 369 eyes progressed slowly\nand 82 rapidly. The Random Forest model combining structural and functional\nfeatures achieved the best performance (AUC = 0.87, 2000 Monte Carlo\niterations). SHAP identified six key predictors: inferior MRW, inferior and\ninferior-temporal RNFL thickness, nasal-temporal LC curvature, superior nasal\nVF sensitivity, and inferior RNFL and GCL+IPL thickness. Models using only\nstructural or functional features performed worse with AUC of 0.82 and 0.78,\nrespectively. Conclusions: Combining ONH structural and VF functional\nparameters significantly improves classification of progression risk in PACG.\nInferior ONH features, MRW and RNFL thickness, were the most predictive,\nhighlighting the critical role of ONH morphology in monitoring disease\nprogression.", "AI": {"tldr": "\u8be5\u7814\u7a76\u8868\u660e\uff0c\u7ed3\u5408\u89c6\u795e\u7ecf\u7ed3\u6784\u548c\u89c6\u91ce\u529f\u80fd\u53ef\u4ee5\u66f4\u51c6\u786e\u5730\u9884\u6d4b\u539f\u53d1\u6027\u95ed\u89d2\u578b\u9752\u5149\u773c\u7684\u8fdb\u5c55\u901f\u5ea6\u3002", "motivation": "\u65e8\u5728\u5229\u7528\u7efc\u5408\u65b9\u6cd5\uff0c\u901a\u8fc7\u7ed3\u5408\u89c6\u795e\u7ecf\u5934\uff08ONH\uff09\u7ed3\u6784\u7279\u5f81\u548c\u57fa\u4e8e\u6247\u533a\u7684\u89c6\u91ce\uff08VF\uff09\u529f\u80fd\u53c2\u6570\uff0c\u5bf9\u539f\u53d1\u6027\u95ed\u89d2\u578b\u9752\u5149\u773c\uff08PACG\uff09\u60a3\u8005\u7684\u773c\u775b\u8fdb\u884c\u5206\u7c7b\uff0c\u5224\u65ad\u5176\u4e3a\u7f13\u6162\u6216\u5feb\u901f\u7684\u9752\u5149\u773c\u8fdb\u5c55\u3002", "method": "\u91c7\u7528\u7ed3\u5408\u89c6\u795e\u7ecf\u5934\uff08ONH\uff09\u7ed3\u6784\u7279\u5f81\u548c\u57fa\u4e8e\u533a\u57df\u7684\u89c6\u91ce\uff08VF\uff09\u529f\u80fd\u53c2\u6570\u7684\u7efc\u5408\u65b9\u6cd5\u3002", "result": "\u5206\u6790\u4e86\u6765\u81ea299\u540d\u60a3\u8005\u7684451\u53ea\u773c\u775b\u3002\u5e73\u5747VFI\u8fdb\u5c55\u4e3a\u6bcf\u5e74-0.92%\uff1b369\u53ea\u773c\u775b\u8fdb\u5c55\u7f13\u6162\uff0c82\u53ea\u773c\u775b\u8fdb\u5c55\u8fc5\u901f\u3002\u7ed3\u5408\u7ed3\u6784\u548c\u529f\u80fd\u7279\u5f81\u7684\u968f\u673a\u68ee\u6797\u6a21\u578b\u53d6\u5f97\u4e86\u6700\u4f73\u6027\u80fd\uff08AUC = 0.87\uff0c2000\u6b21\u8499\u7279\u5361\u7f57\u8fed\u4ee3\uff09\u3002SHAP\u786e\u5b9a\u4e86\u516d\u4e2a\u5173\u952e\u9884\u6d4b\u56e0\u5b50\uff1a\u4e0b\u65b9MRW\u3001\u4e0b\u65b9\u548c\u4e0b\u65b9\u989e\u4fa7RNFL\u539a\u5ea6\u3001\u9f3b\u989e\u4fa7LC\u66f2\u7387\u3001\u4e0a\u65b9\u9f3b\u4fa7VF\u654f\u611f\u5ea6\uff0c\u4ee5\u53ca\u4e0b\u65b9RNFL\u548cGCL+IPL\u539a\u5ea6\u3002\u4ec5\u4f7f\u7528\u7ed3\u6784\u6216\u529f\u80fd\u7279\u5f81\u7684\u6a21\u578b\u8868\u73b0\u8f83\u5dee\uff0cAUC\u5206\u522b\u4e3a0.82\u548c0.78\u3002", "conclusion": "\u7ed3\u5408\u89c6\u795e\u7ecf\u5934\u7ed3\u6784\u548c\u89c6\u91ce\u529f\u80fd\u53c2\u6570\u53ef\u4ee5\u663e\u8457\u63d0\u9ad8\u539f\u53d1\u6027\u95ed\u89d2\u578b\u9752\u5149\u773c\uff08PACG\uff09\u8fdb\u5c55\u98ce\u9669\u7684\u5206\u7c7b\u6548\u679c\uff0c\u5176\u4e2d\u4e0b\u65b9\u89c6\u795e\u7ecf\u5934\u7279\u5f81\uff08MRW \u548c RNFL \u539a\u5ea6\uff09\u662f\u6700\u5177\u9884\u6d4b\u6027\u7684\u3002", "summary_zh": "\u76ee\u7684\uff1a\u65e8\u5728\u4f7f\u7528\u7ed3\u5408\u89c6\u795e\u7ecf\u5934\uff08ONH\uff09\u7ed3\u6784\u7279\u5f81\u548c\u57fa\u4e8e\u6247\u533a\u7684\u89c6\u91ce\uff08VF\uff09\u529f\u80fd\u53c2\u6570\u7684\u7efc\u5408\u65b9\u6cd5\uff0c\u5bf9\u539f\u53d1\u6027\u95ed\u89d2\u578b\u9752\u5149\u773c\uff08PACG\uff09\u60a3\u8005\u7684\u773c\u775b\u8fdb\u884c\u5206\u7c7b\uff0c\u5224\u65ad\u5176\u4e3a\u7f13\u6162\u6216\u5feb\u901f\u7684\u9752\u5149\u773c\u8fdb\u5c55\u3002\u65b9\u6cd5\uff1a\u7eb3\u5165\u4e865\u5e74\u5185\u8fdb\u884c\u4e86>5\u6b21\u53ef\u9760VF\u6d4b\u8bd5\u7684PACG\u60a3\u8005\u3002\u5728\u8521\u53f8\u8bba\u575b\u4e2d\u8bc4\u4f30\u8fdb\u5c55\u60c5\u51b5\uff0c\u57fa\u7ebfVF\u5728OCT\u7684\u516d\u4e2a\u6708\u5185\u3002\u5feb\u901f\u8fdb\u5c55\u5b9a\u4e49\u4e3aVFI\u6bcf\u5e74\u4e0b\u964d<-2.0%\uff1b\u7f13\u6162\u8fdb\u5c55\u5b9a\u4e49\u4e3a\u6bcf\u5e74>-2.0%\u3002\u5bf9OCT\u4f53\u79ef\u8fdb\u884cAI\u5206\u5272\uff0c\u4ee5\u63d0\u53d631\u4e2aONH\u53c2\u6570\u3002\u9752\u5149\u773c\u534a\u89c6\u91ce\u6d4b\u8bd5\u5b9a\u4e49\u4e86\u6bcf\u4e2a\u534a\u89c6\u91ce\u7684\u4e94\u4e2a\u533a\u57df\uff0c\u4e0eRNFL\u5206\u5e03\u5bf9\u9f50\u3002\u5c06\u6bcf\u4e2a\u533a\u57df\u7684\u5e73\u5747\u654f\u611f\u5ea6\u4e0e\u7ed3\u6784\u53c2\u6570\u76f8\u7ed3\u5408\uff0c\u4ee5\u8bad\u7ec3ML\u5206\u7c7b\u5668\u3002\u6d4b\u8bd5\u4e86\u591a\u4e2a\u6a21\u578b\uff0cSHAP\u786e\u5b9a\u4e86\u5173\u952e\u9884\u6d4b\u56e0\u5b50\u3002\u4e3b\u8981\u7ed3\u679c\u6307\u6807\uff1a\u4f7f\u7528\u7ec4\u5408\u7684\u7ed3\u6784\u548c\u529f\u80fd\u6570\u636e\u5bf9\u7f13\u6162\u4e0e\u5feb\u901f\u8fdb\u5c55\u8005\u8fdb\u884c\u5206\u7c7b\u3002\u7ed3\u679c\uff1a\u6211\u4eec\u5206\u6790\u4e86\u6765\u81ea299\u540d\u60a3\u8005\u7684451\u53ea\u773c\u775b\u3002\u5e73\u5747VFI\u8fdb\u5c55\u4e3a\u6bcf\u5e74-0.92%\uff1b369\u53ea\u773c\u775b\u8fdb\u5c55\u7f13\u6162\uff0c82\u53ea\u773c\u775b\u8fdb\u5c55\u8fc5\u901f\u3002\u7ed3\u5408\u7ed3\u6784\u548c\u529f\u80fd\u7279\u5f81\u7684\u968f\u673a\u68ee\u6797\u6a21\u578b\u53d6\u5f97\u4e86\u6700\u4f73\u6027\u80fd\uff08AUC = 0.87\uff0c2000\u6b21\u8499\u7279\u5361\u7f57\u8fed\u4ee3\uff09\u3002SHAP\u786e\u5b9a\u4e86\u516d\u4e2a\u5173\u952e\u9884\u6d4b\u56e0\u5b50\uff1a\u4e0b\u65b9MRW\u3001\u4e0b\u65b9\u548c\u4e0b\u65b9\u989e\u4fa7RNFL\u539a\u5ea6\u3001\u9f3b\u989e\u4fa7LC\u66f2\u7387\u3001\u4e0a\u65b9\u9f3b\u4fa7VF\u654f\u611f\u5ea6\uff0c\u4ee5\u53ca\u4e0b\u65b9RNFL\u548cGCL+IPL\u539a\u5ea6\u3002\u4ec5\u4f7f\u7528\u7ed3\u6784\u6216\u529f\u80fd\u7279\u5f81\u7684\u6a21\u578b\u8868\u73b0\u8f83\u5dee\uff0cAUC\u5206\u522b\u4e3a0.82\u548c0.78\u3002\u7ed3\u8bba\uff1a\u7ed3\u5408ONH\u7ed3\u6784\u548cVF\u529f\u80fd\u53c2\u6570\u53ef\u4ee5\u663e\u8457\u63d0\u9ad8PACG\u8fdb\u5c55\u98ce\u9669\u7684\u5206\u7c7b\u6548\u679c\u3002\u4e0b\u65b9ONH\u7279\u5f81\uff0cMRW\u548cRNFL\u539a\u5ea6\uff0c\u662f\u6700\u5177\u9884\u6d4b\u6027\u7684\uff0c\u7a81\u51fa\u4e86ONH\u5f62\u6001\u5728\u76d1\u6d4b\u75be\u75c5\u8fdb\u5c55\u4e2d\u7684\u5173\u952e\u4f5c\u7528\u3002"}}
{"id": "2508.14936", "pdf": "https://arxiv.org/pdf/2508.14936", "abs": "https://arxiv.org/abs/2508.14936", "authors": ["Jan Kapar", "Kathrin G\u00fcnther", "Lori Ann Vallis", "Klaus Berger", "Nadine Binder", "Hermann Brenner", "Stefanie Castell", "Beate Fischer", "Volker Harth", "Bernd Holleczek", "Timm Intemann", "Till Ittermann", "Andr\u00e9 Karch", "Thomas Keil", "Lilian Krist", "Berit Lange", "Michael F. Leitzmann", "Katharina Nimptsch", "Nadia Obi", "Iris Pigeot", "Tobias Pischon", "Tamara Schikowski", "B\u00f6rge Schmidt", "Carsten Oliver Schmidt", "Anja M. Sedlmair", "Justine Tanoey", "Harm Wienbergen", "Andreas Wienke", "Claudia Wigmann", "Marvin N. Wright"], "title": "Can synthetic data reproduce real-world findings in epidemiology? A replication study using tree-based generative AI", "categories": ["q-bio.QM", "cs.AI", "cs.LG", "stat.AP", "stat.ML"], "comment": null, "summary": "Generative artificial intelligence for synthetic data generation holds\nsubstantial potential to address practical challenges in epidemiology. However,\nmany current methods suffer from limited quality, high computational demands,\nand complexity for non-experts. Furthermore, common evaluation strategies for\nsynthetic data often fail to directly reflect statistical utility. Against this\nbackground, a critical underexplored question is whether synthetic data can\nreliably reproduce key findings from epidemiological research. We propose the\nuse of adversarial random forests (ARF) as an efficient and convenient method\nfor synthesizing tabular epidemiological data. To evaluate its performance, we\nreplicated statistical analyses from six epidemiological publications and\ncompared original with synthetic results. These publications cover blood\npressure, anthropometry, myocardial infarction, accelerometry, loneliness, and\ndiabetes, based on data from the German National Cohort (NAKO\nGesundheitsstudie), the Bremen STEMI Registry U45 Study, and the Guelph Family\nHealth Study. Additionally, we assessed the impact of dimensionality and\nvariable complexity on synthesis quality by limiting datasets to variables\nrelevant for individual analyses, including necessary derivations. Across all\nreplicated original studies, results from multiple synthetic data replications\nconsistently aligned with original findings. Even for datasets with relatively\nlow sample size-to-dimensionality ratios, the replication outcomes closely\nmatched the original results across various descriptive and inferential\nanalyses. Reducing dimensionality and pre-deriving variables further enhanced\nboth quality and stability of the results.", "AI": {"tldr": "\u8be5\u8bba\u6587\u63d0\u51fa\u4f7f\u7528\u5bf9\u6297\u968f\u673a\u68ee\u6797\uff08ARF\uff09\u751f\u6210\u9ad8\u8d28\u91cf\u7684\u5408\u6210\u6d41\u884c\u75c5\u5b66\u6570\u636e\uff0c\u5e76\u9a8c\u8bc1\u4e86\u5176\u5728\u91cd\u73b0\u539f\u59cb\u7814\u7a76\u7ed3\u679c\u65b9\u9762\u7684\u6709\u6548\u6027\u3002", "motivation": "\u751f\u6210\u7528\u4e8e\u5408\u6210\u6570\u636e\u751f\u6210\u7684\u4eba\u5de5\u667a\u80fd\u5177\u6709\u89e3\u51b3\u6d41\u884c\u75c5\u5b66\u5b9e\u9645\u6311\u6218\u7684\u5de8\u5927\u6f5c\u529b\u3002\u7136\u800c\uff0c\u8bb8\u591a\u5f53\u524d\u7684\u65b9\u6cd5\u5b58\u5728\u8d28\u91cf\u6709\u9650\u3001\u8ba1\u7b97\u9700\u6c42\u9ad8\u4ee5\u53ca\u5bf9\u4e8e\u975e\u4e13\u4e1a\u4eba\u58eb\u6765\u8bf4\u590d\u6742\u7684\u95ee\u9898\u3002\u6b64\u5916\uff0c\u5e38\u89c1\u7684\u5408\u6210\u6570\u636e\u8bc4\u4f30\u7b56\u7565\u901a\u5e38\u4e0d\u80fd\u76f4\u63a5\u53cd\u6620\u7edf\u8ba1\u6548\u7528\u3002\u5728\u8fd9\u79cd\u80cc\u666f\u4e0b\uff0c\u4e00\u4e2a\u5173\u952e\u7684\u672a\u88ab\u5145\u5206\u63a2\u7d22\u7684\u95ee\u9898\u662f\u5408\u6210\u6570\u636e\u662f\u5426\u80fd\u591f\u53ef\u9760\u5730\u91cd\u73b0\u6d41\u884c\u75c5\u5b66\u7814\u7a76\u4e2d\u7684\u5173\u952e\u53d1\u73b0\u3002", "method": "\u6211\u4eec\u5efa\u8bae\u4f7f\u7528\u5bf9\u6297\u968f\u673a\u68ee\u6797 (ARF) \u4f5c\u4e3a\u4e00\u79cd\u6709\u6548\u4e14\u65b9\u4fbf\u7684\u65b9\u6cd5\u6765\u5408\u6210\u8868\u683c\u6d41\u884c\u75c5\u5b66\u6570\u636e\u3002", "result": "\u4e3a\u4e86\u8bc4\u4f30\u5176\u6027\u80fd\uff0c\u6211\u4eec\u590d\u5236\u4e86\u516d\u7bc7\u6d41\u884c\u75c5\u5b66\u51fa\u7248\u7269\u4e2d\u7684\u7edf\u8ba1\u5206\u6790\uff0c\u5e76\u5c06\u539f\u59cb\u7ed3\u679c\u4e0e\u5408\u6210\u7ed3\u679c\u8fdb\u884c\u4e86\u6bd4\u8f83\u3002\u8fd9\u4e9b\u51fa\u7248\u7269\u57fa\u4e8e\u5fb7\u56fd\u56fd\u5bb6\u961f\u5217\uff08NAKO Gesundheitsstudie\uff09\u3001\u4e0d\u83b1\u6885 STEMI \u6ce8\u518c U45 \u7814\u7a76\u548c\u572d\u5c14\u592b\u5bb6\u5ead\u5065\u5eb7\u7814\u7a76\u7684\u6570\u636e\uff0c\u6db5\u76d6\u4e86\u8840\u538b\u3001\u4eba\u4f53\u6d4b\u91cf\u5b66\u3001\u5fc3\u808c\u6897\u585e\u3001\u52a0\u901f\u8ba1\u3001\u5b64\u72ec\u75c7\u548c\u7cd6\u5c3f\u75c5\u3002\u6b64\u5916\uff0c\u6211\u4eec\u901a\u8fc7\u5c06\u6570\u636e\u96c6\u9650\u5236\u4e3a\u4e0e\u4e2a\u4f53\u5206\u6790\u76f8\u5173\u7684\u53d8\u91cf\uff08\u5305\u62ec\u5fc5\u8981\u7684\u63a8\u5bfc\uff09\uff0c\u8bc4\u4f30\u4e86\u7ef4\u5ea6\u548c\u53d8\u91cf\u590d\u6742\u6027\u5bf9\u5408\u6210\u8d28\u91cf\u7684\u5f71\u54cd\u3002", "conclusion": "\u5728\u6240\u6709\u590d\u5236\u7684\u539f\u59cb\u7814\u7a76\u4e2d\uff0c\u6765\u81ea\u591a\u4e2a\u5408\u6210\u6570\u636e\u590d\u5236\u7684\u7ed3\u679c\u4e0e\u539f\u59cb\u53d1\u73b0\u4e00\u81f4\u3002\u5373\u4f7f\u5bf9\u4e8e\u6837\u672c\u91cf\u4e0e\u7ef4\u5ea6\u6bd4\u7387\u76f8\u5bf9\u8f83\u4f4e\u7684\u6570\u636e\u96c6\uff0c\u590d\u5236\u7ed3\u679c\u4e5f\u4e0e\u5404\u79cd\u63cf\u8ff0\u6027\u548c\u63a8\u8bba\u6027\u5206\u6790\u7684\u539f\u59cb\u7ed3\u679c\u975e\u5e38\u5339\u914d\u3002\u964d\u4f4e\u7ef4\u5ea6\u548c\u9884\u5148\u5bfc\u51fa\u53d8\u91cf\u8fdb\u4e00\u6b65\u63d0\u9ad8\u4e86\u7ed3\u679c\u7684\u8d28\u91cf\u548c\u7a33\u5b9a\u6027\u3002", "summary_zh": "\u7528\u4e8e\u5408\u6210\u6570\u636e\u751f\u6210\u7684\u751f\u6210\u5f0f\u4eba\u5de5\u667a\u80fd\u5177\u6709\u89e3\u51b3\u6d41\u884c\u75c5\u5b66\u5b9e\u9645\u6311\u6218\u7684\u5de8\u5927\u6f5c\u529b\u3002\u7136\u800c\uff0c\u8bb8\u591a\u5f53\u524d\u7684\u65b9\u6cd5\u5b58\u5728\u8d28\u91cf\u6709\u9650\u3001\u8ba1\u7b97\u9700\u6c42\u9ad8\u4ee5\u53ca\u5bf9\u4e8e\u975e\u4e13\u4e1a\u4eba\u58eb\u6765\u8bf4\u590d\u6742\u7684\u95ee\u9898\u3002\u6b64\u5916\uff0c\u5e38\u89c1\u7684\u5408\u6210\u6570\u636e\u8bc4\u4f30\u7b56\u7565\u901a\u5e38\u4e0d\u80fd\u76f4\u63a5\u53cd\u6620\u7edf\u8ba1\u6548\u7528\u3002\u5728\u8fd9\u79cd\u80cc\u666f\u4e0b\uff0c\u4e00\u4e2a\u5173\u952e\u7684\u672a\u88ab\u5145\u5206\u63a2\u7d22\u7684\u95ee\u9898\u662f\u5408\u6210\u6570\u636e\u662f\u5426\u80fd\u591f\u53ef\u9760\u5730\u91cd\u73b0\u6d41\u884c\u75c5\u5b66\u7814\u7a76\u4e2d\u7684\u5173\u952e\u53d1\u73b0\u3002\u6211\u4eec\u5efa\u8bae\u4f7f\u7528\u5bf9\u6297\u968f\u673a\u68ee\u6797 (ARF) \u4f5c\u4e3a\u4e00\u79cd\u6709\u6548\u4e14\u65b9\u4fbf\u7684\u65b9\u6cd5\u6765\u5408\u6210\u8868\u683c\u6d41\u884c\u75c5\u5b66\u6570\u636e\u3002\u4e3a\u4e86\u8bc4\u4f30\u5176\u6027\u80fd\uff0c\u6211\u4eec\u590d\u5236\u4e86\u516d\u7bc7\u6d41\u884c\u75c5\u5b66\u51fa\u7248\u7269\u4e2d\u7684\u7edf\u8ba1\u5206\u6790\uff0c\u5e76\u5c06\u539f\u59cb\u7ed3\u679c\u4e0e\u5408\u6210\u7ed3\u679c\u8fdb\u884c\u4e86\u6bd4\u8f83\u3002\u8fd9\u4e9b\u51fa\u7248\u7269\u57fa\u4e8e\u5fb7\u56fd\u56fd\u5bb6\u961f\u5217\uff08NAKO Gesundheitsstudie\uff09\u3001\u4e0d\u83b1\u6885 STEMI \u6ce8\u518c U45 \u7814\u7a76\u548c\u572d\u5c14\u592b\u5bb6\u5ead\u5065\u5eb7\u7814\u7a76\u7684\u6570\u636e\uff0c\u6db5\u76d6\u4e86\u8840\u538b\u3001\u4eba\u4f53\u6d4b\u91cf\u5b66\u3001\u5fc3\u808c\u6897\u585e\u3001\u52a0\u901f\u8ba1\u3001\u5b64\u72ec\u75c7\u548c\u7cd6\u5c3f\u75c5\u3002\u6b64\u5916\uff0c\u6211\u4eec\u901a\u8fc7\u5c06\u6570\u636e\u96c6\u9650\u5236\u4e3a\u4e0e\u4e2a\u4f53\u5206\u6790\u76f8\u5173\u7684\u53d8\u91cf\uff08\u5305\u62ec\u5fc5\u8981\u7684\u63a8\u5bfc\uff09\uff0c\u8bc4\u4f30\u4e86\u7ef4\u5ea6\u548c\u53d8\u91cf\u590d\u6742\u6027\u5bf9\u5408\u6210\u8d28\u91cf\u7684\u5f71\u54cd\u3002\u5728\u6240\u6709\u590d\u5236\u7684\u539f\u59cb\u7814\u7a76\u4e2d\uff0c\u6765\u81ea\u591a\u4e2a\u5408\u6210\u6570\u636e\u590d\u5236\u7684\u7ed3\u679c\u4e0e\u539f\u59cb\u53d1\u73b0\u4e00\u81f4\u3002\u5373\u4f7f\u5bf9\u4e8e\u6837\u672c\u91cf\u4e0e\u7ef4\u5ea6\u6bd4\u7387\u76f8\u5bf9\u8f83\u4f4e\u7684\u6570\u636e\u96c6\uff0c\u590d\u5236\u7ed3\u679c\u4e5f\u4e0e\u5404\u79cd\u63cf\u8ff0\u6027\u548c\u63a8\u8bba\u6027\u5206\u6790\u7684\u539f\u59cb\u7ed3\u679c\u975e\u5e38\u5339\u914d\u3002\u964d\u4f4e\u7ef4\u5ea6\u548c\u9884\u5148\u5bfc\u51fa\u53d8\u91cf\u8fdb\u4e00\u6b65\u63d0\u9ad8\u4e86\u7ed3\u679c\u7684\u8d28\u91cf\u548c\u7a33\u5b9a\u6027\u3002"}}
{"id": "2508.15034", "pdf": "https://arxiv.org/pdf/2508.15034", "abs": "https://arxiv.org/abs/2508.15034", "authors": ["Mahdi Bagheri", "Clemente Velasco-Annis", "Jian Wang", "Razieh Faghihpirayesh", "Shadab Khan", "Camilo Calixto", "Camilo Jaimes", "Lana Vasung", "Abdelhakim Ouaalam", "Onur Afacan", "Simon K. Warfield", "Caitlin K. Rollins", "Ali Gholipour"], "title": "An MRI Atlas of the Human Fetal Brain: Reference and Segmentation Tools for Fetal Brain MRI Analysis", "categories": ["q-bio.QM"], "comment": null, "summary": "Accurate characterization of in-utero brain development is essential for\nunderstanding typical and atypical neurodevelopment. Building upon previous\nefforts to construct spatiotemporal fetal brain MRI atlases, we present the\nCRL-2025 fetal brain atlas, which is a spatiotemporal (4D) atlas of the\ndeveloping fetal brain between 21 and 37 gestational weeks. This atlas is\nconstructed from carefully processed MRI scans of 160 fetuses with\ntypically-developing brains using a diffeomorphic deformable registration\nframework integrated with kernel regression on age. CRL-2025 uniquely includes\ndetailed tissue segmentations, transient white matter compartments, and\nparcellation into 126 anatomical regions. This atlas offers significantly\nenhanced anatomical details over the CRL-2017 atlas, and is released along with\nthe CRL diffusion MRI atlas with its newly created tissue segmentation and\nlabels as well as deep learning-based multiclass segmentation models for\nfine-grained fetal brain MRI segmentation. The CRL-2025 atlas and its\nassociated tools provide a robust and scalable platform for fetal brain MRI\nsegmentation, groupwise analysis, and early neurodevelopmental research, and\nthese materials are publicly released to support the broader research\ncommunity.", "AI": {"tldr": "CRL-2025\u80ce\u513f\u8111\u56fe\u8c31\u662f\u4e00\u4e2a\u65f6\u7a7a\u56fe\u8c31\uff0c\u5b83\u63d0\u4f9b\u4e86\u589e\u5f3a\u7684\u89e3\u5256\u7ec6\u8282\uff0c\u5e76\u5e26\u6709\u7ec4\u7ec7\u5206\u5272\u548c\u6df1\u5ea6\u5b66\u4e60\u5206\u5272\u6a21\u578b\u3002", "motivation": "\u7cbe\u786e\u63cf\u8ff0\u5b50\u5bab\u5185\u5927\u8111\u53d1\u80b2\u5bf9\u4e8e\u7406\u89e3\u5178\u578b\u548c\u975e\u5178\u578b\u795e\u7ecf\u53d1\u80b2\u81f3\u5173\u91cd\u8981\u3002", "method": "\u8be5\u56fe\u8c31\u662f\u5229\u7528160\u540d\u5177\u6709\u5178\u578b\u53d1\u80b2\u5927\u8111\u7684\u80ce\u513f\u7684\u7ecf\u8fc7\u4ed4\u7ec6\u5904\u7406\u7684MRI\u626b\u63cf\u6784\u5efa\u7684\uff0c\u4f7f\u7528\u4e86\u4e00\u79cd\u4e0e\u5e74\u9f84\u76f8\u5173\u7684\u5f62\u53d8\u914d\u51c6\u6846\u67b6\u3002", "result": "CRL-2025\u72ec\u7279\u5730\u5305\u62ec\u8be6\u7ec6\u7684\u7ec4\u7ec7\u5206\u5272\u3001\u77ac\u65f6\u767d\u8d28\u533a\u5ba4\u548c\u5206\u5272\u6210126\u4e2a\u89e3\u5256\u533a\u57df\u3002\u4e0eCRL-2017\u56fe\u8c31\u76f8\u6bd4\uff0c\u8be5\u56fe\u8c31\u63d0\u4f9b\u4e86\u663e\u7740\u589e\u5f3a\u7684\u89e3\u5256\u7ec6\u8282\uff0c\u5e76\u4e0eCRL\u5f25\u6563MRI\u56fe\u8c31\u53ca\u5176\u65b0\u521b\u5efa\u7684\u7ec4\u7ec7\u5206\u5272\u548c\u6807\u7b7e\u4ee5\u53ca\u7528\u4e8e\u7cbe\u7ec6\u80ce\u513f\u8111MRI\u5206\u5272\u7684\u57fa\u4e8e\u6df1\u5ea6\u5b66\u4e60\u7684\u591a\u7c7b\u5206\u5272\u6a21\u578b\u4e00\u8d77\u53d1\u5e03\u3002", "conclusion": "CRL-2025\u56fe\u8c31\u53ca\u5176\u76f8\u5173\u5de5\u5177\u4e3a\u80ce\u513f\u8111MRI\u5206\u5272\u3001\u5206\u7ec4\u5206\u6790\u548c\u65e9\u671f\u795e\u7ecf\u53d1\u80b2\u7814\u7a76\u63d0\u4f9b\u4e86\u4e00\u4e2a\u5f3a\u5927\u4e14\u53ef\u6269\u5c55\u7684\u5e73\u53f0\uff0c\u8fd9\u4e9b\u6750\u6599\u5df2\u516c\u5f00\u53d1\u5e03\uff0c\u4ee5\u652f\u6301\u66f4\u5e7f\u6cdb\u7684\u7814\u7a76\u793e\u533a\u3002", "summary_zh": "\u7cbe\u786e\u63cf\u8ff0\u5b50\u5bab\u5185\u5927\u8111\u53d1\u80b2\u5bf9\u4e8e\u7406\u89e3\u5178\u578b\u548c\u975e\u5178\u578b\u795e\u7ecf\u53d1\u80b2\u81f3\u5173\u91cd\u8981\u3002\u5728\u5148\u524d\u6784\u5efa\u65f6\u7a7a\u80ce\u513f\u8111MRI\u56fe\u8c31\u7684\u57fa\u7840\u4e0a\uff0c\u6211\u4eec\u63d0\u51fa\u4e86CRL-2025\u80ce\u513f\u8111\u56fe\u8c31\uff0c\u8fd9\u662f\u4e00\u4e2a\u4ecb\u4e8e21\u523037\u5b55\u5468\u4e4b\u95f4\u7684\u53d1\u80b2\u4e2d\u80ce\u513f\u8111\u7684\u65f6\u7a7a\uff084D\uff09\u56fe\u8c31\u3002\u8be5\u56fe\u8c31\u662f\u5229\u7528160\u540d\u5177\u6709\u5178\u578b\u53d1\u80b2\u5927\u8111\u7684\u80ce\u513f\u7684\u7ecf\u8fc7\u4ed4\u7ec6\u5904\u7406\u7684MRI\u626b\u63cf\u6784\u5efa\u7684\uff0c\u4f7f\u7528\u4e86\u4e00\u79cd\u4e0e\u5e74\u9f84\u76f8\u5173\u7684\u5f62\u53d8\u914d\u51c6\u6846\u67b6\u3002CRL-2025\u72ec\u7279\u5730\u5305\u62ec\u8be6\u7ec6\u7684\u7ec4\u7ec7\u5206\u5272\u3001\u77ac\u65f6\u767d\u8d28\u533a\u5ba4\u548c\u5206\u5272\u6210126\u4e2a\u89e3\u5256\u533a\u57df\u3002\u4e0eCRL-2017\u56fe\u8c31\u76f8\u6bd4\uff0c\u8be5\u56fe\u8c31\u63d0\u4f9b\u4e86\u663e\u7740\u589e\u5f3a\u7684\u89e3\u5256\u7ec6\u8282\uff0c\u5e76\u4e0eCRL\u5f25\u6563MRI\u56fe\u8c31\u53ca\u5176\u65b0\u521b\u5efa\u7684\u7ec4\u7ec7\u5206\u5272\u548c\u6807\u7b7e\u4ee5\u53ca\u7528\u4e8e\u7cbe\u7ec6\u80ce\u513f\u8111MRI\u5206\u5272\u7684\u57fa\u4e8e\u6df1\u5ea6\u5b66\u4e60\u7684\u591a\u7c7b\u5206\u5272\u6a21\u578b\u4e00\u8d77\u53d1\u5e03\u3002CRL-2025\u56fe\u8c31\u53ca\u5176\u76f8\u5173\u5de5\u5177\u4e3a\u80ce\u513f\u8111MRI\u5206\u5272\u3001\u5206\u7ec4\u5206\u6790\u548c\u65e9\u671f\u795e\u7ecf\u53d1\u80b2\u7814\u7a76\u63d0\u4f9b\u4e86\u4e00\u4e2a\u5f3a\u5927\u4e14\u53ef\u6269\u5c55\u7684\u5e73\u53f0\uff0c\u8fd9\u4e9b\u6750\u6599\u5df2\u516c\u5f00\u53d1\u5e03\uff0c\u4ee5\u652f\u6301\u66f4\u5e7f\u6cdb\u7684\u7814\u7a76\u793e\u533a\u3002"}}
{"id": "2508.14997", "pdf": "https://arxiv.org/pdf/2508.14997", "abs": "https://arxiv.org/abs/2508.14997", "authors": ["Xin Gao", "Michael Lanz", "Rosslyn Grosely", "Jonas Cremer", "Joseph Puglisi", "Jan M. Skotheim"], "title": "Yeast growth is controlled by the proportional scaling of mRNA and ribosome concentrations", "categories": ["q-bio.PE", "q-bio.BM"], "comment": "57 pages, 4 figures", "summary": "Despite growth being fundamental to all aspects of cell biology, we do not\nyet know its organizing principles in eukaryotic cells. Classic models derived\nfrom the bacteria E. coli posit that protein-synthesis rates are set by\nmass-action collisions between charged tRNAs produced by metabolic enzymes and\nmRNA-bound ribosomes. These models show that faster growth is achieved by\nsimultaneously raising both ribosome content and peptide elongation speed.\nHere, we test if these models are valid for eukaryotes by combining\nsingle-molecule tracking, spike-in RNA sequencing, and proteomics in 15 carbon-\nand nitrogen-limited conditions using the budding yeast S. cerevisiae. Ribosome\nconcentration increases linearly with growth rate, as in bacteria, but the\npeptide elongation speed remains constant (~9 amino acids/s) and charged tRNAs\nare not limiting. Total mRNA concentration rises in direct proportion to\nribosomes, driven by enhanced RNA polymerase II occupancy of the genome. We\nshow that a simple kinetic model of mRNA-ribosome binding predicts both the\nfraction of active ribosomes, the growth rate, and responses to transcriptional\nperturbations. Yeast accelerate growth by coordinately and proportionally\nco-up-regulating total mRNA and ribosome concentrations, not by speeding\nelongation. Taken together, our work establishes a new framework for eukaryotic\ngrowth control and resource allocation.", "AI": {"tldr": "\u9175\u6bcd\u901a\u8fc7\u534f\u8c03\u4e0a\u8c03mRNA\u548c\u6838\u7cd6\u4f53\u6d53\u5ea6\u6765\u52a0\u901f\u751f\u957f\uff0c\u800c\u975e\u52a0\u901f\u5ef6\u4f38\u3002", "motivation": "\u5c3d\u7ba1\u751f\u957f\u662f\u7ec6\u80de\u751f\u7269\u5b66\u6240\u6709\u65b9\u9762\u7684\u57fa\u7840\uff0c\u4f46\u6211\u4eec\u4ecd\u7136\u4e0d\u77e5\u9053\u5176\u5728\u771f\u6838\u7ec6\u80de\u4e2d\u7684\u7ec4\u7ec7\u539f\u5219\u3002\u7ecf\u5178\u7684\u6765\u81ea\u5927\u80a0\u6746\u83ccE. coli\u7684\u6a21\u578b\u5047\u8bbe\u86cb\u767d\u8d28\u5408\u6210\u901f\u7387\u662f\u7531\u4ee3\u8c22\u9176\u4ea7\u751f\u7684\u5e26\u7535tRNA\u4e0emRNA\u7ed3\u5408\u7684\u6838\u7cd6\u4f53\u4e4b\u95f4\u7684\u8d28\u91cf\u4f5c\u7528\u78b0\u649e\u51b3\u5b9a\u7684\u3002\u8fd9\u4e9b\u6a21\u578b\u8868\u660e\uff0c\u901a\u8fc7\u540c\u65f6\u63d0\u9ad8\u6838\u7cd6\u4f53\u542b\u91cf\u548c\u80bd\u94fe\u5ef6\u4f38\u901f\u5ea6\u53ef\u4ee5\u5b9e\u73b0\u66f4\u5feb\u7684\u751f\u957f\u3002", "method": "\u7ed3\u5408\u5355\u5206\u5b50\u8ffd\u8e2a\u3001spike-in RNA\u6d4b\u5e8f\u548c\u86cb\u767d\u8d28\u7ec4\u5b66\uff0c\u572815\u79cd\u78b3\u548c\u6c2e\u9650\u5236\u6761\u4ef6\u4e0b\uff0c\u4f7f\u7528\u51fa\u82bd\u9175\u6bcdS. cerevisiae\u3002", "result": "\u6838\u7cd6\u4f53\u6d53\u5ea6\u968f\u751f\u957f\u901f\u7387\u7ebf\u6027\u589e\u52a0\uff0c\u4e0e\u7ec6\u83cc\u4e2d\u4e00\u6837\uff0c\u4f46\u80bd\u94fe\u5ef6\u4f38\u901f\u5ea6\u4fdd\u6301\u6052\u5b9a\uff08~9\u4e2a\u6c28\u57fa\u9178/\u79d2\uff09\uff0c\u5e26\u7535tRNA\u4e0d\u662f\u9650\u5236\u56e0\u7d20\u3002\u603bmRNA\u6d53\u5ea6\u4e0e\u6838\u7cd6\u4f53\u6210\u6b63\u6bd4\u4e0a\u5347\uff0c\u8fd9\u662f\u7531RNA\u805a\u5408\u9176II\u5bf9\u57fa\u56e0\u7ec4\u7684\u5360\u636e\u589e\u5f3a\u9a71\u52a8\u7684\u3002", "conclusion": "\u9175\u6bcd\u901a\u8fc7\u534f\u8c03\u4e14\u6210\u6bd4\u4f8b\u5730\u5171\u540c\u4e0a\u8c03\u603bmRNA\u548c\u6838\u7cd6\u4f53\u6d53\u5ea6\u6765\u52a0\u901f\u751f\u957f\uff0c\u800c\u4e0d\u662f\u901a\u8fc7\u52a0\u901f\u5ef6\u4f38\u3002", "summary_zh": "\u5c3d\u7ba1\u7ec6\u80de\u751f\u957f\u662f\u7ec6\u80de\u751f\u7269\u5b66\u5404\u4e2a\u65b9\u9762\u7684\u57fa\u7840\uff0c\u4f46\u6211\u4eec\u5bf9\u771f\u6838\u7ec6\u80de\u4e2d\u7ec6\u80de\u751f\u957f\u7684\u7ec4\u7ec7\u539f\u5219\u4ecd\u7136\u77e5\u4e4b\u751a\u5c11\u3002\u7ecf\u5178\u7684\u5927\u80a0\u6746\u83cc\u6a21\u578b\u8ba4\u4e3a\uff0c\u86cb\u767d\u8d28\u5408\u6210\u901f\u7387\u53d6\u51b3\u4e8e\u5e26\u7535tRNA\u4e0emRNA\u7ed3\u5408\u7684\u6838\u7cd6\u4f53\u4e4b\u95f4\u7684\u8d28\u91cf\u4f5c\u7528\u78b0\u649e\u3002\u8fd9\u4e9b\u6a21\u578b\u8868\u660e\uff0c\u63d0\u9ad8\u6838\u7cd6\u4f53\u542b\u91cf\u548c\u80bd\u94fe\u5ef6\u4f38\u901f\u5ea6\u53ef\u4ee5\u52a0\u5feb\u7ec6\u80de\u751f\u957f\u3002\u4e3a\u4e86\u9a8c\u8bc1\u8fd9\u4e9b\u6a21\u578b\u662f\u5426\u9002\u7528\u4e8e\u771f\u6838\u751f\u7269\uff0c\u6211\u4eec\u7ed3\u5408\u4e86\u5355\u5206\u5b50\u8ffd\u8e2a\u3001\u5b9a\u91cfRNA\u6d4b\u5e8f\u548c\u86cb\u767d\u8d28\u7ec4\u5b66\u6280\u672f\uff0c\u572815\u79cd\u78b3\u6c2e\u53d7\u9650\u7684\u6761\u4ef6\u4e0b\uff0c\u7814\u7a76\u4e86\u51fa\u82bd\u9175\u6bcd\u83cc\u3002\u7814\u7a76\u53d1\u73b0\uff0c\u4e0e\u7ec6\u83cc\u7c7b\u4f3c\uff0c\u6838\u7cd6\u4f53\u6d53\u5ea6\u968f\u751f\u957f\u901f\u7387\u7ebf\u6027\u589e\u52a0\uff0c\u4f46\u80bd\u94fe\u5ef6\u4f38\u901f\u5ea6\u4fdd\u6301\u4e0d\u53d8\uff08\u7ea69\u4e2a\u6c28\u57fa\u9178/\u79d2\uff09\uff0c\u4e14\u5e26\u7535tRNA\u5e76\u975e\u9650\u5236\u56e0\u7d20\u3002\u603bmRNA\u6d53\u5ea6\u4e0e\u6838\u7cd6\u4f53\u6d53\u5ea6\u6210\u6b63\u6bd4\u589e\u52a0\uff0c\u8fd9\u662f\u7531RNA\u805a\u5408\u9176II\u5728\u57fa\u56e0\u7ec4\u4e0a\u7684\u5360\u6709\u7387\u63d0\u9ad8\u6240\u9a71\u52a8\u7684\u3002\u6211\u4eec\u53d1\u73b0\uff0c\u4e00\u4e2a\u7b80\u5355\u7684mRNA-\u6838\u7cd6\u4f53\u7ed3\u5408\u52a8\u529b\u5b66\u6a21\u578b\u53ef\u4ee5\u9884\u6d4b\u6d3b\u6027\u6838\u7cd6\u4f53\u7684\u6bd4\u4f8b\u3001\u751f\u957f\u901f\u7387\u4ee5\u53ca\u5bf9\u8f6c\u5f55\u6270\u52a8\u7684\u54cd\u5e94\u3002\u9175\u6bcd\u901a\u8fc7\u534f\u8c03\u4e14\u6210\u6bd4\u4f8b\u5730\u5171\u540c\u4e0a\u8c03\u603bmRNA\u548c\u6838\u7cd6\u4f53\u6d53\u5ea6\u6765\u52a0\u901f\u751f\u957f\uff0c\u800c\u4e0d\u662f\u901a\u8fc7\u52a0\u901f\u5ef6\u4f38\u3002\u603b\u800c\u8a00\u4e4b\uff0c\u6211\u4eec\u7684\u5de5\u4f5c\u4e3a\u771f\u6838\u7ec6\u80de\u751f\u957f\u63a7\u5236\u548c\u8d44\u6e90\u5206\u914d\u5efa\u7acb\u4e86\u4e00\u4e2a\u65b0\u7684\u6846\u67b6\u3002"}}
{"id": "2508.15046", "pdf": "https://arxiv.org/pdf/2508.15046", "abs": "https://arxiv.org/abs/2508.15046", "authors": ["Shih-Huan Huang", "Matthew W. Cotton", "Tuomas P. J. Knowles", "David Klenerman", "Georg Meisl"], "title": "A cell-level model to predict the spatiotemporal dynamics of neurodegenerative disease", "categories": ["q-bio.QM", "cond-mat.soft"], "comment": null, "summary": "A central challenge in modeling neurodegenerative diseases is connecting\ncellular-level mechanisms to tissue-level pathology, in particular to determine\nwhether pathology is driven primarily by cell-autonomous triggers or by\npropagation from cells that are already in a pathological, runaway aggregation\nstate. To bridge this gap, we here develop a bottom-up physical model that\nexplicitly incorporates these two fundamental cell-level drivers of protein\naggregation dynamics. We show that our model naturally explains the\ncharacteristic long, slow development of pathology followed by a rapid\nacceleration, a hallmark of many neurodegenerative diseases. Furthermore, the\nmodel reveals the existence of a critical switch point at which the system's\ndynamics transition from being dominated by slow, spontaneous formation of\ndiseased cells to being driven by fast propagation. This framework provides a\nrobust physical foundation for interpreting pathological data and offers a\nmethod to predict which class of therapeutic strategies is best matched to the\nunderlying drivers of a specific disease.", "AI": {"tldr": "\u8be5\u8bba\u6587\u63d0\u51fa\u4e86\u4e00\u4e2a\u7269\u7406\u6a21\u578b\uff0c\u7528\u4e8e\u89e3\u91ca\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u4e2d\u75c5\u7406\u53d1\u5c55\u7684\u957f\u671f\u7f13\u6162\u52a0\u901f\u73b0\u8c61\uff0c\u5e76\u63ed\u793a\u4e86\u75be\u75c5\u53d1\u5c55\u4e2d\u7684\u4e34\u754c\u8f6c\u6362\u70b9\u3002", "motivation": "\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u5efa\u6a21\u7684\u6838\u5fc3\u6311\u6218\u662f\u5c06\u7ec6\u80de\u6c34\u5e73\u7684\u673a\u5236\u4e0e\u7ec4\u7ec7\u6c34\u5e73\u7684\u75c5\u7406\u8054\u7cfb\u8d77\u6765\uff0c\u7279\u522b\u662f\u786e\u5b9a\u75c5\u7406\u4e3b\u8981\u662f\u7531\u7ec6\u80de\u81ea\u4e3b\u89e6\u53d1\u56e0\u7d20\u9a71\u52a8\uff0c\u8fd8\u662f\u7531\u5df2\u7ecf\u5904\u4e8e\u75c5\u7406\u72b6\u6001\u7684\u7ec6\u80de\u7684\u4f20\u64ad\u9a71\u52a8\u3002", "method": "\u8be5\u7814\u7a76\u5efa\u7acb\u4e86\u4e00\u4e2a\u81ea\u4e0b\u800c\u4e0a\u7684\u7269\u7406\u6a21\u578b\uff0c\u8be5\u6a21\u578b\u660e\u786e\u5730\u5305\u542b\u4e86\u86cb\u767d\u8d28\u805a\u96c6\u52a8\u529b\u5b66\u7684\u4e24\u4e2a\u57fa\u672c\u7ec6\u80de\u6c34\u5e73\u9a71\u52a8\u56e0\u7d20\u3002", "result": "\u8be5\u6a21\u578b\u81ea\u7136\u5730\u89e3\u91ca\u4e86\u8bb8\u591a\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u7684\u7279\u5f81\u6027\u75c5\u7406\u53d1\u5c55\u8fc7\u7a0b\uff0c\u5373\u957f\u671f\u7f13\u6162\u53d1\u5c55\uff0c\u7136\u540e\u8fc5\u901f\u52a0\u901f\u3002\u6b64\u5916\uff0c\u8be5\u6a21\u578b\u63ed\u793a\u4e86\u4e00\u4e2a\u4e34\u754c\u8f6c\u6362\u70b9\uff0c\u5728\u8be5\u70b9\u4e0a\uff0c\u7cfb\u7edf\u52a8\u529b\u5b66\u4ece\u53d7\u7f13\u6162\u7684\u3001\u81ea\u53d1\u7684\u75c5\u53d8\u7ec6\u80de\u5f62\u6210\u652f\u914d\u8f6c\u53d8\u4e3a\u53d7\u5feb\u901f\u4f20\u64ad\u9a71\u52a8\u3002", "conclusion": "\u8be5\u6a21\u578b\u4e3a\u89e3\u91ca\u75c5\u7406\u6570\u636e\u548c\u9884\u6d4b\u6cbb\u7597\u7b56\u7565\u63d0\u4f9b\u4e86\u7269\u7406\u57fa\u7840\u3002", "summary_zh": "\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u5efa\u6a21\u7684\u4e00\u4e2a\u6838\u5fc3\u6311\u6218\u662f\u5c06\u7ec6\u80de\u6c34\u5e73\u7684\u673a\u5236\u4e0e\u7ec4\u7ec7\u6c34\u5e73\u7684\u75c5\u7406\u8054\u7cfb\u8d77\u6765\uff0c\u7279\u522b\u662f\u786e\u5b9a\u75c5\u7406\u4e3b\u8981\u662f\u7531\u7ec6\u80de\u81ea\u4e3b\u89e6\u53d1\u56e0\u7d20\u9a71\u52a8\uff0c\u8fd8\u662f\u7531\u5df2\u7ecf\u5904\u4e8e\u75c5\u7406\u72b6\u6001\u3001\u5931\u63a7\u805a\u96c6\u72b6\u6001\u7684\u7ec6\u80de\u7684\u4f20\u64ad\u9a71\u52a8\u3002\u4e3a\u4e86\u5f25\u5408\u8fd9\u4e00\u5dee\u8ddd\uff0c\u6211\u4eec\u5728\u6b64\u5f00\u53d1\u4e86\u4e00\u4e2a\u81ea\u4e0b\u800c\u4e0a\u7684\u7269\u7406\u6a21\u578b\uff0c\u8be5\u6a21\u578b\u660e\u786e\u5730\u5305\u542b\u4e86\u86cb\u767d\u8d28\u805a\u96c6\u52a8\u529b\u5b66\u7684\u8fd9\u4e24\u4e2a\u57fa\u672c\u7ec6\u80de\u6c34\u5e73\u9a71\u52a8\u56e0\u7d20\u3002\u6211\u4eec\u8868\u660e\uff0c\u6211\u4eec\u7684\u6a21\u578b\u81ea\u7136\u5730\u89e3\u91ca\u4e86\u8bb8\u591a\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u7684\u7279\u5f81\u6027\u75c5\u7406\u53d1\u5c55\u8fc7\u7a0b\uff0c\u5373\u957f\u671f\u7f13\u6162\u53d1\u5c55\uff0c\u7136\u540e\u8fc5\u901f\u52a0\u901f\uff0c\u8fd9\u662f\u8bb8\u591a\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u7684\u6807\u5fd7\u3002\u6b64\u5916\uff0c\u8be5\u6a21\u578b\u63ed\u793a\u4e86\u4e00\u4e2a\u4e34\u754c\u8f6c\u6362\u70b9\uff0c\u5728\u8be5\u70b9\u4e0a\uff0c\u7cfb\u7edf\u52a8\u529b\u5b66\u4ece\u53d7\u7f13\u6162\u7684\u3001\u81ea\u53d1\u7684\u75c5\u53d8\u7ec6\u80de\u5f62\u6210\u652f\u914d\u8f6c\u53d8\u4e3a\u53d7\u5feb\u901f\u4f20\u64ad\u9a71\u52a8\u3002\u8be5\u6846\u67b6\u4e3a\u89e3\u91ca\u75c5\u7406\u6570\u636e\u63d0\u4f9b\u4e86\u4e00\u4e2a\u5f3a\u5927\u7684\u7269\u7406\u57fa\u7840\uff0c\u5e76\u63d0\u4f9b\u4e86\u4e00\u79cd\u9884\u6d4b\u54ea\u4e00\u7c7b\u6cbb\u7597\u7b56\u7565\u6700\u9002\u5408\u7279\u5b9a\u75be\u75c5\u7684\u6f5c\u5728\u9a71\u52a8\u56e0\u7d20\u7684\u65b9\u6cd5\u3002"}}
{"id": "2508.15077", "pdf": "https://arxiv.org/pdf/2508.15077", "abs": "https://arxiv.org/abs/2508.15077", "authors": ["Samik Datta", "Vincent X Lomas", "Nicole Satherley", "Andrew Sporle", "Michael J Plank"], "title": "Modelling the transmission and impact of Omicron variants of Covid-19 in different ethnicity groups in Aotearoa New Zealand", "categories": ["q-bio.PE"], "comment": null, "summary": "Previous pandemics, including influenza pandemics and Covid-19, have\ndisproportionately impacted M\\=aori and Pacific populations in Aotearoa New\nZealand. The reasons for this are multi-faceted, including differences in\nsocioeconomic deprivation, housing conditions and household size, vaccination\nrates, access to healthcare, and prevalence of pre-existing health conditions.\nMany mathematical models that were used to inform the response to the Covid-19\npandemic did not explicitly include ethnicity or other socioeconomic variables.\nThis limited their ability to predict, understand and mitigate inequitable\nimpacts of the pandemic. Here, we extend a model that was developed during the\nCovid-19 pandemic to support the public health response by stratifying the\npopulation into four ethnicity groups: M\\=aori, Pacific, Asian and\nEuropean/other. We include three ethnicity-specific components in the model:\nvaccination rates, clinical severity parameters, and contact patterns. We\ncompare model results to ethnicity-specific data on Covid-19 cases, hospital\nadmissions and deaths between 1 January 2022 and 30 June 2023, under different\nmodel scenarios in which these ethnicity-specific components are present or\nabsent. We find that differences in vaccination rates explain only part of the\nobserved disparities in outcomes. While no model scenario is able to fully\ncapture the heterogeneous temporal dynamics, our results suggest that\ndifferences between ethnicities in the per-infection risk of clinical severe\ndisease is an important factor. Our work is an important step towards models\nthat are better able to predict inequitable impacts of future pandemic and\nemerging disease threats, and investigate the ability of interventions to\nmitigate these.", "AI": {"tldr": "\u8be5\u7814\u7a76\u901a\u8fc7\u6784\u5efa\u5305\u542b\u79cd\u65cf\u56e0\u7d20\u7684\u6570\u5b66\u6a21\u578b\uff0c\u53d1\u73b0\u4e0d\u540c\u65cf\u88d4\u4eba\u7fa4\u611f\u67d3\u540e\u60a3\u4e25\u91cd\u75be\u75c5\u7684\u98ce\u9669\u5dee\u5f02\u662f\u9020\u6210\u5065\u5eb7\u7ed3\u679c\u4e0d\u5e73\u7b49\u7684\u91cd\u8981\u56e0\u7d20\u3002", "motivation": "\u4ee5\u5f80\u7684\u75ab\u60c5\uff0c\u5305\u62ec\u6d41\u611f\u548c Covid-19\uff0c\u5bf9\u65b0\u897f\u5170\u7684\u6bdb\u5229\u4eba\u548c\u592a\u5e73\u6d0b\u5c9b\u6c11\u4eba\u53e3\u9020\u6210\u4e86\u4e0d\u6210\u6bd4\u4f8b\u7684\u5f71\u54cd\u3002\u8bb8\u591a\u7528\u4e8e\u5e94\u5bf9 Covid-19 \u75ab\u60c5\u7684\u6570\u5b66\u6a21\u578b\u6ca1\u6709\u660e\u786e\u5305\u542b\u79cd\u65cf\u6216\u5176\u4ed6\u793e\u4f1a\u7ecf\u6d4e\u53d8\u91cf\uff0c\u8fd9\u9650\u5236\u4e86\u5b83\u4eec\u9884\u6d4b\u3001\u7406\u89e3\u548c\u51cf\u8f7b\u75ab\u60c5\u4e0d\u516c\u5e73\u5f71\u54cd\u7684\u80fd\u529b\u3002", "method": "\u8be5\u7814\u7a76\u6269\u5c55\u4e86\u65b0\u51a0\u75ab\u60c5\u671f\u95f4\u5f00\u53d1\u7684\u6a21\u578b\uff0c\u5c06\u4eba\u53e3\u5206\u4e3a\u6bdb\u5229\u4eba\u3001\u592a\u5e73\u6d0b\u5c9b\u6c11\u3001\u4e9a\u6d32\u4eba\u548c\u6b27\u6d32\u4eba/\u5176\u4ed6\u4eba\u56db\u4e2a\u79cd\u65cf\u7fa4\u4f53\uff0c\u5e76\u5728\u6a21\u578b\u4e2d\u52a0\u5165\u4e86\u4e09\u4e2a\u7279\u5b9a\u4e8e\u79cd\u65cf\u7684\u7ec4\u6210\u90e8\u5206\uff1a\u75ab\u82d7\u63a5\u79cd\u7387\u3001\u4e34\u5e8a\u4e25\u91cd\u7a0b\u5ea6\u53c2\u6570\u548c\u63a5\u89e6\u6a21\u5f0f\u3002", "result": "\u7814\u7a76\u53d1\u73b0\uff0c\u75ab\u82d7\u63a5\u79cd\u7387\u7684\u5dee\u5f02\u53ea\u80fd\u89e3\u91ca\u89c2\u5bdf\u5230\u7684\u7ed3\u679c\u5dee\u5f02\u7684\u4e00\u90e8\u5206\u3002\u867d\u7136\u6ca1\u6709\u6a21\u578b\u573a\u666f\u80fd\u591f\u5b8c\u5168\u6355\u6349\u5230\u5f02\u8d28\u7684\u65f6\u95f4\u52a8\u6001\uff0c\u4f46\u7ed3\u679c\u8868\u660e\uff0c\u4e0d\u540c\u79cd\u65cf\u5728\u6bcf\u6b21\u611f\u67d3\u4e2d\u60a3\u4e34\u5e8a\u91cd\u75c7\u75be\u75c5\u7684\u98ce\u9669\u5dee\u5f02\u662f\u4e00\u4e2a\u91cd\u8981\u56e0\u7d20\u3002", "conclusion": "\u4e0d\u540c\u65cf\u88d4\u4eba\u7fa4\u611f\u67d3\u540e\u60a3\u4e25\u91cd\u75be\u75c5\u7684\u98ce\u9669\u5dee\u5f02\u662f\u9020\u6210\u5065\u5eb7\u7ed3\u679c\u4e0d\u5e73\u7b49\u7684\u91cd\u8981\u56e0\u7d20\u3002", "summary_zh": "\u4ee5\u5f80\u7684\u75ab\u60c5\uff0c\u5305\u62ec\u6d41\u611f\u548c Covid-19\uff0c\u5bf9\u65b0\u897f\u5170\u7684\u6bdb\u5229\u4eba\u548c\u592a\u5e73\u6d0b\u5c9b\u6c11\u4eba\u53e3\u9020\u6210\u4e86\u4e0d\u6210\u6bd4\u4f8b\u7684\u5f71\u54cd\u3002\u9020\u6210\u8fd9\u79cd\u60c5\u51b5\u7684\u539f\u56e0\u662f\u591a\u65b9\u9762\u7684\uff0c\u5305\u62ec\u793e\u4f1a\u7ecf\u6d4e\u5265\u593a\u3001\u4f4f\u623f\u6761\u4ef6\u548c\u5bb6\u5ead\u89c4\u6a21\u3001\u75ab\u82d7\u63a5\u79cd\u7387\u3001\u83b7\u5f97\u533b\u7597\u4fdd\u5065\u7684\u673a\u4f1a\u4ee5\u53ca\u5148\u524d\u5b58\u5728\u7684\u5065\u5eb7\u72b6\u51b5\u7684\u5dee\u5f02\u3002\u8bb8\u591a\u7528\u4e8e\u5e94\u5bf9 Covid-19 \u75ab\u60c5\u7684\u6570\u5b66\u6a21\u578b\u6ca1\u6709\u660e\u786e\u5305\u542b\u79cd\u65cf\u6216\u5176\u4ed6\u793e\u4f1a\u7ecf\u6d4e\u53d8\u91cf\u3002\u8fd9\u9650\u5236\u4e86\u5b83\u4eec\u9884\u6d4b\u3001\u7406\u89e3\u548c\u51cf\u8f7b\u75ab\u60c5\u4e0d\u516c\u5e73\u5f71\u54cd\u7684\u80fd\u529b\u3002\u5728\u8fd9\u91cc\uff0c\u6211\u4eec\u6269\u5c55\u4e86\u5728 Covid-19 \u75ab\u60c5\u671f\u95f4\u5f00\u53d1\u7684\u6a21\u578b\uff0c\u901a\u8fc7\u5c06\u4eba\u53e3\u5206\u4e3a\u56db\u4e2a\u79cd\u65cf\u7fa4\u4f53\u6765\u652f\u6301\u516c\u5171\u536b\u751f\u5e94\u5bf9\uff1a\u6bdb\u5229\u4eba\u3001\u592a\u5e73\u6d0b\u5c9b\u6c11\u3001\u4e9a\u6d32\u4eba\u548c\u6b27\u6d32\u4eba/\u5176\u4ed6\u4eba\u3002\u6211\u4eec\u5728\u6a21\u578b\u4e2d\u52a0\u5165\u4e86\u4e09\u4e2a\u7279\u5b9a\u4e8e\u79cd\u65cf\u7684\u7ec4\u6210\u90e8\u5206\uff1a\u75ab\u82d7\u63a5\u79cd\u7387\u3001\u4e34\u5e8a\u4e25\u91cd\u7a0b\u5ea6\u53c2\u6570\u548c\u63a5\u89e6\u6a21\u5f0f\u3002\u6211\u4eec\u5c06\u6a21\u578b\u7ed3\u679c\u4e0e 2022 \u5e74 1 \u6708 1 \u65e5\u81f3 2023 \u5e74 6 \u6708 30 \u65e5\u671f\u95f4 Covid-19 \u75c5\u4f8b\u3001\u4f4f\u9662\u4eba\u6570\u548c\u6b7b\u4ea1\u4eba\u6570\u7684\u7279\u5b9a\u79cd\u65cf\u6570\u636e\u8fdb\u884c\u6bd4\u8f83\uff0c\u5728\u4e0d\u540c\u7684\u6a21\u578b\u573a\u666f\u4e2d\uff0c\u8fd9\u4e9b\u7279\u5b9a\u79cd\u65cf\u7684\u7ec4\u6210\u90e8\u5206\u5b58\u5728\u6216\u4e0d\u5b58\u5728\u3002\u6211\u4eec\u53d1\u73b0\uff0c\u75ab\u82d7\u63a5\u79cd\u7387\u7684\u5dee\u5f02\u53ea\u80fd\u89e3\u91ca\u89c2\u5bdf\u5230\u7684\u7ed3\u679c\u5dee\u5f02\u7684\u4e00\u90e8\u5206\u3002\u867d\u7136\u6ca1\u6709\u6a21\u578b\u573a\u666f\u80fd\u591f\u5b8c\u5168\u6355\u6349\u5230\u5f02\u8d28\u7684\u65f6\u95f4\u52a8\u6001\uff0c\u4f46\u6211\u4eec\u7684\u7ed3\u679c\u8868\u660e\uff0c\u4e0d\u540c\u79cd\u65cf\u5728\u6bcf\u6b21\u611f\u67d3\u4e2d\u60a3\u4e34\u5e8a\u91cd\u75c7\u75be\u75c5\u7684\u98ce\u9669\u5dee\u5f02\u662f\u4e00\u4e2a\u91cd\u8981\u56e0\u7d20\u3002\u6211\u4eec\u7684\u5de5\u4f5c\u662f\u671d\u7740\u80fd\u591f\u66f4\u597d\u9884\u6d4b\u672a\u6765\u75ab\u60c5\u548c\u65b0\u53d1\u75be\u75c5\u5a01\u80c1\u7684\u4e0d\u516c\u5e73\u5f71\u54cd\uff0c\u5e76\u8c03\u67e5\u5e72\u9884\u63aa\u65bd\u51cf\u8f7b\u8fd9\u4e9b\u5f71\u54cd\u7684\u80fd\u529b\u7684\u6a21\u578b\u8fc8\u51fa\u7684\u91cd\u8981\u4e00\u6b65\u3002"}}
{"id": "2508.15103", "pdf": "https://arxiv.org/pdf/2508.15103", "abs": "https://arxiv.org/abs/2508.15103", "authors": ["Mehdi Yazdani-Jahromi", "Ali Khodabandeh Yalabadi", "Ozlem Ozmen Garibay"], "title": "Equi-mRNA: Protein Translation Equivariant Encoding for mRNA Language Models", "categories": ["q-bio.QM", "cs.AI"], "comment": null, "summary": "The growing importance of mRNA therapeutics and synthetic biology highlights\nthe need for models that capture the latent structure of synonymous codon\n(different triplets encoding the same amino acid) usage, which subtly modulates\ntranslation efficiency and gene expression. While recent efforts incorporate\ncodon-level inductive biases through auxiliary objectives, they often fall\nshort of explicitly modeling the structured relationships that arise from the\ngenetic code's inherent symmetries. We introduce Equi-mRNA, the first\ncodon-level equivariant mRNA language model that explicitly encodes synonymous\ncodon symmetries as cyclic subgroups of 2D Special Orthogonal matrix (SO(2)).\nBy combining group-theoretic priors with an auxiliary equivariance loss and\nsymmetry-aware pooling, Equi-mRNA learns biologically grounded representations\nthat outperform vanilla baselines across multiple axes. On downstream\nproperty-prediction tasks including expression, stability, and riboswitch\nswitching Equi-mRNA delivers up to approximately 10% improvements in accuracy.\nIn sequence generation, it produces mRNA constructs that are up to\napproximately 4x more realistic under Frechet BioDistance metrics and\napproximately 28% better preserve functional properties compared to vanilla\nbaseline. Interpretability analyses further reveal that learned codon-rotation\ndistributions recapitulate known GC-content biases and tRNA abundance patterns,\noffering novel insights into codon usage. Equi-mRNA establishes a new\nbiologically principled paradigm for mRNA modeling, with significant\nimplications for the design of next-generation therapeutics.", "AI": {"tldr": "Equi-mRNA \u662f\u9996\u4e2a\u5bc6\u7801\u5b50\u6c34\u5e73\u7684\u7b49\u53d8 mRNA \u8bed\u8a00\u6a21\u578b\uff0c\u5b83\u901a\u8fc7\u663e\u5f0f\u7f16\u7801\u540c\u4e49\u5bc6\u7801\u5b50\u5bf9\u79f0\u6027\uff0c\u5728 mRNA \u5efa\u6a21\u65b9\u9762\u53d6\u5f97\u4e86\u751f\u7269\u5b66\u4e0a\u7684\u7a81\u7834\u3002", "motivation": "mRNA \u7597\u6cd5\u548c\u5408\u6210\u751f\u7269\u5b66\u7684\u91cd\u8981\u6027\u65e5\u76ca\u589e\u52a0\uff0c\u8fd9\u7a81\u663e\u4e86\u5bf9\u80fd\u591f\u6355\u6349\u540c\u4e49\u5bc6\u7801\u5b50\uff08\u7f16\u7801\u76f8\u540c\u6c28\u57fa\u9178\u7684\u4e0d\u540c\u4e09\u8054\u4f53\uff09\u4f7f\u7528\u60c5\u51b5\u7684\u6f5c\u5728\u7ed3\u6784\u7684\u6a21\u578b\u7684\u9700\u6c42\uff0c\u8fd9\u79cd\u7ed3\u6784\u5fae\u5999\u5730\u8c03\u8282\u7740\u7ffb\u8bd1\u6548\u7387\u548c\u57fa\u56e0\u8868\u8fbe\u3002", "method": "Equi-mRNA \u662f\u7b2c\u4e00\u4e2a\u5bc6\u7801\u5b50\u6c34\u5e73\u7684\u7b49\u53d8 mRNA \u8bed\u8a00\u6a21\u578b\uff0c\u5b83\u5c06\u540c\u4e49\u5bc6\u7801\u5b50\u5bf9\u79f0\u6027\u663e\u5f0f\u7f16\u7801\u4e3a 2D \u7279\u6b8a\u6b63\u4ea4\u77e9\u9635 (SO(2)) \u7684\u5faa\u73af\u5b50\u7fa4\u3002\u901a\u8fc7\u5c06\u7fa4\u8bba\u5148\u9a8c\u4e0e\u8f85\u52a9\u7b49\u53d8\u635f\u5931\u548c\u5bf9\u79f0\u611f\u77e5\u6c60\u5316\u76f8\u7ed3\u5408\u3002", "result": "\u5728\u5305\u62ec\u8868\u8fbe\u3001\u7a33\u5b9a\u6027\u548c\u6838\u7cd6\u5f00\u5173\u8f6c\u6362\u5728\u5185\u7684\u4e0b\u6e38\u7279\u6027\u9884\u6d4b\u4efb\u52a1\u4e2d\uff0cEqui-mRNA \u63d0\u4f9b\u7684\u51c6\u786e\u6027\u63d0\u9ad8\u4e86\u7ea6 10%\u3002\u5728\u5e8f\u5217\u751f\u6210\u4e2d\uff0c\u4e0e\u539f\u59cb\u57fa\u7ebf\u76f8\u6bd4\uff0c\u5b83\u4ea7\u751f\u7684 mRNA \u7ed3\u6784\u5728 Frechet BioDistance \u6307\u6807\u4e0b\u903c\u771f\u5ea6\u63d0\u9ad8\u4e86\u7ea6 4 \u500d\uff0c\u529f\u80fd\u7279\u6027\u4fdd\u7559\u5ea6\u63d0\u9ad8\u4e86\u7ea6 28%\u3002", "conclusion": "Equi-mRNA \u5f15\u5165\u4e86\u4e00\u79cd\u65b0\u7684\u3001\u5177\u6709\u751f\u7269\u5b66\u539f\u7406\u7684 mRNA \u5efa\u6a21\u8303\u4f8b\uff0c\u5bf9\u4e0b\u4e00\u4ee3\u7597\u6cd5\u7684\u8bbe\u8ba1\u5177\u6709\u91cd\u8981\u610f\u4e49\u3002", "summary_zh": "mRNA \u7597\u6cd5\u548c\u5408\u6210\u751f\u7269\u5b66\u65e5\u76ca\u91cd\u8981\uff0c\u56e0\u6b64\u9700\u8981\u80fd\u591f\u6355\u6349\u540c\u4e49\u5bc6\u7801\u5b50\u4f7f\u7528\u6f5c\u5728\u7ed3\u6784\u7684\u6a21\u578b\uff0c\u56e0\u4e3a\u5bc6\u7801\u5b50\u7684\u4f7f\u7528\u4f1a\u5fae\u5999\u5730\u8c03\u8282\u7ffb\u8bd1\u6548\u7387\u548c\u57fa\u56e0\u8868\u8fbe\u3002\u867d\u7136\u6700\u8fd1\u7684\u7814\u7a76\u8bd5\u56fe\u901a\u8fc7\u8f85\u52a9\u76ee\u6807\u6574\u5408\u5bc6\u7801\u5b50\u6c34\u5e73\u7684\u5f52\u7eb3\u504f\u7f6e\uff0c\u4f46\u5b83\u4eec\u901a\u5e38\u672a\u80fd\u660e\u786e\u5730\u6a21\u62df\u7531\u9057\u4f20\u5bc6\u7801\u7684\u5185\u5728\u5bf9\u79f0\u6027\u4ea7\u751f\u7684\u7ed3\u6784\u5316\u5173\u7cfb\u3002\u6211\u4eec\u5f15\u5165\u4e86 Equi-mRNA\uff0c\u8fd9\u662f\u7b2c\u4e00\u4e2a\u5bc6\u7801\u5b50\u6c34\u5e73\u7684\u7b49\u53d8 mRNA \u8bed\u8a00\u6a21\u578b\uff0c\u5b83\u5c06\u540c\u4e49\u5bc6\u7801\u5b50\u5bf9\u79f0\u6027\u663e\u5f0f\u7f16\u7801\u4e3a 2D \u7279\u6b8a\u6b63\u4ea4\u77e9\u9635 (SO(2)) \u7684\u5faa\u73af\u5b50\u7fa4\u3002\u901a\u8fc7\u5c06\u7fa4\u8bba\u5148\u9a8c\u4e0e\u8f85\u52a9\u7b49\u53d8\u635f\u5931\u548c\u5bf9\u79f0\u611f\u77e5\u6c60\u5316\u76f8\u7ed3\u5408\uff0cEqui-mRNA \u5b66\u4e60\u5230\u7684\u5177\u6709\u751f\u7269\u5b66\u57fa\u7840\u7684\u8868\u5f81\u4f18\u4e8e\u591a\u4e2a\u65b9\u9762\u7684\u539f\u59cb\u57fa\u7ebf\u3002\u5728\u5305\u62ec\u8868\u8fbe\u3001\u7a33\u5b9a\u6027\u548c\u6838\u7cd6\u5f00\u5173\u8f6c\u6362\u5728\u5185\u7684\u4e0b\u6e38\u7279\u6027\u9884\u6d4b\u4efb\u52a1\u4e2d\uff0cEqui-mRNA \u63d0\u4f9b\u7684\u51c6\u786e\u6027\u63d0\u9ad8\u4e86\u7ea6 10%\u3002\u5728\u5e8f\u5217\u751f\u6210\u4e2d\uff0c\u4e0e\u539f\u59cb\u57fa\u7ebf\u76f8\u6bd4\uff0c\u5b83\u4ea7\u751f\u7684 mRNA \u7ed3\u6784\u5728 Frechet BioDistance \u6307\u6807\u4e0b\u903c\u771f\u5ea6\u63d0\u9ad8\u4e86\u7ea6 4 \u500d\uff0c\u529f\u80fd\u7279\u6027\u4fdd\u7559\u5ea6\u63d0\u9ad8\u4e86\u7ea6 28%\u3002\u89e3\u91ca\u6027\u5206\u6790\u8fdb\u4e00\u6b65\u8868\u660e\uff0c\u5b66\u4e60\u5230\u7684\u5bc6\u7801\u5b50\u65cb\u8f6c\u5206\u5e03\u6982\u62ec\u4e86\u5df2\u77e5\u7684 GC \u542b\u91cf\u504f\u5dee\u548c tRNA \u4e30\u5ea6\u6a21\u5f0f\uff0c\u4e3a\u5bc6\u7801\u5b50\u4f7f\u7528\u63d0\u4f9b\u4e86\u65b0\u7684\u89c1\u89e3\u3002Equi-mRNA \u5efa\u7acb\u4e86\u4e00\u79cd\u65b0\u7684\u3001\u5177\u6709\u751f\u7269\u5b66\u539f\u7406\u7684 mRNA \u5efa\u6a21\u8303\u4f8b\uff0c\u5bf9\u4e0b\u4e00\u4ee3\u7597\u6cd5\u7684\u8bbe\u8ba1\u5177\u6709\u91cd\u8981\u610f\u4e49\u3002"}}
{"id": "2508.15533", "pdf": "https://arxiv.org/pdf/2508.15533", "abs": "https://arxiv.org/abs/2508.15533", "authors": ["Yangjing Long", "Tong Wang"], "title": "Defining a phylogenetic tree with the minimum number of small-state characters", "categories": ["q-bio.PE", "math.CO"], "comment": null, "summary": "Phylogenetic trees represent evolutionary relationships and can be uniquely\ndefined by sets of finite-state biological characteristics. Despite prior work\nshowing that sufficiently large trees can be determined by $r$-state character\nsets, the minimal leaf thresholds $n_r$ remain largely unknown. In this work,\nwe establish the 3-state case as $n_3 = 8$, providing a concrete base for\nhigher-state analyses. We then resolve the 5-state problem by constructing a\ncounterexample for $n=15$ and proving that for $n \\geq 16$, $\\lceil (n-3)/4\n\\rceil$ 5-state characters suffice to uniquely define any tree. Our approach\nrelies on rigorous mathematical induction with complete verification of base\ncases and logically consistent inductive steps, offering new insights into the\nminimal conditions for character-based tree identification.", "AI": {"tldr": "\u8be5\u8bba\u6587\u786e\u5b9a\u4e86\u7528\u6709\u9650\u72b6\u6001\u7279\u5f81\u96c6\u552f\u4e00\u786e\u5b9a\u7cfb\u7edf\u53d1\u80b2\u6811\u6240\u9700\u7684\u6700\u5c0f\u53f6\u5b50\u6570\u91cf\u7684\u4e0b\u754c\uff0c\u89e3\u51b3\u4e863\u72b6\u6001\u548c5\u72b6\u6001\u7684\u95ee\u9898\u3002", "motivation": "\u786e\u5b9a\u53ef\u4ee5\u7528r\u72b6\u6001\u7279\u5f81\u96c6\u786e\u5b9a\u8db3\u591f\u5927\u7684\u6811\u7684\u6700\u5c0f\u53f6\u9608\u503cnr\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u4ecd\u7136\u672a\u77e5\u3002", "method": "\u8be5\u7814\u7a76\u91c7\u7528\u4e25\u683c\u7684\u6570\u5b66\u5f52\u7eb3\u6cd5\uff0c\u5b8c\u5168\u9a8c\u8bc1\u4e86\u57fa\u7840\u6848\u4f8b\uff0c\u5e76\u4f7f\u7528\u4e86\u903b\u8f91\u4e0a\u4e00\u81f4\u7684\u5f52\u7eb3\u6b65\u9aa4\u3002", "result": "\u786e\u5b9a\u4e863\u72b6\u6001\u60c5\u51b5\u4e3an3 = 8\uff0c\u4e3a\u66f4\u9ad8\u72b6\u6001\u5206\u6790\u63d0\u4f9b\u4e86\u5177\u4f53\u7684\u57fa\u7840\u3002\u901a\u8fc7\u6784\u5efan=15\u7684\u53cd\u4f8b\u89e3\u51b3\u4e865\u72b6\u6001\u95ee\u9898\uff0c\u5e76\u8bc1\u660e\u5bf9\u4e8en\u226516\uff0c\u2308(n-3)/4\u2309\u4e2a5\u72b6\u6001\u7279\u5f81\u8db3\u4ee5\u552f\u4e00\u786e\u5b9a\u4efb\u4f55\u6811\u3002", "conclusion": "\u901a\u8fc7\u4e25\u683c\u7684\u6570\u5b66\u5f52\u7eb3\u6cd5\uff0c\u7ed3\u5408\u5bf9\u57fa\u7840\u6848\u4f8b\u7684\u5b8c\u6574\u9a8c\u8bc1\u548c\u903b\u8f91\u4e0a\u4e00\u81f4\u7684\u5f52\u7eb3\u6b65\u9aa4\uff0c\u4e3a\u57fa\u4e8e\u7279\u5f81\u7684\u6811\u8bc6\u522b\u7684\u6700\u5c0f\u6761\u4ef6\u63d0\u4f9b\u4e86\u65b0\u7684\u89c1\u89e3\u3002", "summary_zh": "\u7cfb\u7edf\u53d1\u80b2\u6811\u4ee3\u8868\u4e86\u8fdb\u5316\u5173\u7cfb\uff0c\u5e76\u4e14\u53ef\u4ee5\u7531\u6709\u9650\u72b6\u6001\u751f\u7269\u5b66\u7279\u5f81\u96c6\u552f\u4e00\u786e\u5b9a\u3002\u5c3d\u7ba1\u5148\u524d\u7684\u5de5\u4f5c\u8868\u660e\uff0c\u8db3\u591f\u5927\u7684\u6811\u53ef\u4ee5\u901a\u8fc7r\u72b6\u6001\u7279\u5f81\u96c6\u6765\u786e\u5b9a\uff0c\u4f46\u662f\u6700\u5c0f\u53f6\u9608\u503cnr\u5728\u5f88\u5927\u7a0b\u5ea6\u4e0a\u4ecd\u7136\u672a\u77e5\u3002\u5728\u8fd9\u9879\u5de5\u4f5c\u4e2d\uff0c\u6211\u4eec\u5c063\u72b6\u6001\u60c5\u51b5\u786e\u5b9a\u4e3an3 = 8\uff0c\u4e3a\u66f4\u9ad8\u72b6\u6001\u5206\u6790\u63d0\u4f9b\u4e86\u5177\u4f53\u7684\u57fa\u7840\u3002\u7136\u540e\uff0c\u6211\u4eec\u901a\u8fc7\u6784\u5efan=15\u7684\u53cd\u4f8b\u89e3\u51b3\u4e865\u72b6\u6001\u95ee\u9898\uff0c\u5e76\u8bc1\u660e\u5bf9\u4e8en\u226516\uff0c\u2308(n-3)/4\u2309\u4e2a5\u72b6\u6001\u7279\u5f81\u8db3\u4ee5\u552f\u4e00\u786e\u5b9a\u4efb\u4f55\u6811\u3002\u6211\u4eec\u7684\u65b9\u6cd5\u4f9d\u8d56\u4e8e\u4e25\u683c\u7684\u6570\u5b66\u5f52\u7eb3\u6cd5\uff0c\u7ed3\u5408\u5bf9\u57fa\u7840\u6848\u4f8b\u7684\u5b8c\u6574\u9a8c\u8bc1\u548c\u903b\u8f91\u4e0a\u4e00\u81f4\u7684\u5f52\u7eb3\u6b65\u9aa4\uff0c\u4e3a\u57fa\u4e8e\u7279\u5f81\u7684\u6811\u8bc6\u522b\u7684\u6700\u5c0f\u6761\u4ef6\u63d0\u4f9b\u4e86\u65b0\u7684\u89c1\u89e3\u3002"}}
{"id": "2508.14932", "pdf": "https://arxiv.org/pdf/2508.14932", "abs": "https://arxiv.org/abs/2508.14932", "authors": ["Jiacheng Xie", "Ziyang Zhang", "Biplab Poudel", "Congyu Guo", "Yang Yu", "Guanghui An", "Xiaoting Tang", "Lening Zhao", "Chunhui Xu", "Dong Xu"], "title": "TOM: An Open-Source Tongue Segmentation Method with Multi-Teacher Distillation and Task-Specific Data Augmentation", "categories": ["eess.IV", "cs.AI", "q-bio.QM"], "comment": "Tongue segmentation, data augmentation, synthetic data for AI\n  training, prompt engineering, Segment Anything Model, knowledge distillation,\n  tongue classification", "summary": "Tongue imaging serves as a valuable diagnostic tool, particularly in\nTraditional Chinese Medicine (TCM). The quality of tongue surface segmentation\nsignificantly affects the accuracy of tongue image classification and\nsubsequent diagnosis in intelligent tongue diagnosis systems. However, existing\nresearch on tongue image segmentation faces notable limitations, and there is a\nlack of robust and user-friendly segmentation tools. This paper proposes a\ntongue image segmentation model (TOM) based on multi-teacher knowledge\ndistillation. By incorporating a novel diffusion-based data augmentation\nmethod, we enhanced the generalization ability of the segmentation model while\nreducing its parameter size. Notably, after reducing the parameter count by\n96.6% compared to the teacher models, the student model still achieves an\nimpressive segmentation performance of 95.22% mIoU. Furthermore, we packaged\nand deployed the trained model as both an online and offline segmentation tool\n(available at https://itongue.cn/), allowing TCM practitioners and researchers\nto use it without any programming experience. We also present a case study on\nTCM constitution classification using segmented tongue patches. Experimental\nresults demonstrate that training with tongue patches yields higher\nclassification performance and better interpretability than original tongue\nimages. To our knowledge, this is the first open-source and freely available\ntongue image segmentation tool.", "AI": {"tldr": "\u63d0\u51fa\u4e86\u4e00\u79cd\u57fa\u4e8e\u77e5\u8bc6\u84b8\u998f\u7684\u820c\u8c61\u5206\u5272\u6a21\u578b\uff0c\u5e76\u5f00\u6e90\u4e86\u4e00\u4e2a\u5728\u7ebf/\u79bb\u7ebf\u820c\u8c61\u5206\u5272\u5de5\u5177\uff0c\u7528\u4e8e\u63d0\u9ad8\u4e2d\u533b\u4f53\u8d28\u5206\u7c7b\u7684\u6027\u80fd\u548c\u53ef\u89e3\u91ca\u6027\u3002", "motivation": "\u820c\u8c61\u5206\u5272\u8d28\u91cf\u5f71\u54cd\u820c\u8c61\u5206\u7c7b\u548c\u8bca\u65ad\u7684\u51c6\u786e\u6027\uff0c\u4f46\u73b0\u6709\u7814\u7a76\u5b58\u5728\u5c40\u9650\u6027\uff0c\u7f3a\u4e4f\u7a33\u5065\u6613\u7528\u7684\u5206\u5272\u5de5\u5177\u3002", "method": "\u63d0\u51fa\u4e86\u4e00\u79cd\u57fa\u4e8e\u591a\u6559\u5e08\u77e5\u8bc6\u84b8\u998f\u7684\u820c\u8c61\u5206\u5272\u6a21\u578b\uff08TOM\uff09\uff0c\u5e76\u7ed3\u5408\u6269\u6563\u7684\u6570\u636e\u589e\u5f3a\u65b9\u6cd5\u3002", "result": "\u5b66\u751f\u6a21\u578b\u5728\u53c2\u6570\u91cf\u51cf\u5c1196.6%\u7684\u60c5\u51b5\u4e0b\uff0c\u4ecd\u8fbe\u523095.22%\u7684mIoU\u5206\u5272\u6027\u80fd\u3002\u5728\u7ebf\u548c\u79bb\u7ebf\u5206\u5272\u5de5\u5177\u5df2\u90e8\u7f72\uff08https://itongue.cn/\uff09\u3002\u4f7f\u7528\u5206\u5272\u540e\u7684\u820c\u8c61patch\u8fdb\u884c\u8bad\u7ec3\uff0c\u63d0\u9ad8\u4e86\u5206\u7c7b\u6027\u80fd\u548c\u53ef\u89e3\u91ca\u6027\u3002", "conclusion": "\u901a\u8fc7\u820c\u8c61\u5206\u5272\u5de5\u5177\u548c\u820c\u8c61patch\u8bad\u7ec3\uff0c\u63d0\u9ad8\u4e86\u4e2d\u533b\u4f53\u8d28\u5206\u7c7b\u7684\u6027\u80fd\u548c\u53ef\u89e3\u91ca\u6027\uff0c\u5e76\u9996\u6b21\u5f00\u6e90\u53d1\u5e03\u3002", "summary_zh": "\u820c\u8c61\u6210\u50cf\u662f\u4e00\u79cd\u6709\u4ef7\u503c\u7684\u8bca\u65ad\u5de5\u5177\uff0c\u5c24\u5176\u662f\u5728\u4e2d\u533b\uff08TCM\uff09\u4e2d\u3002\u820c\u9762\u5206\u5272\u7684\u8d28\u91cf\u663e\u8457\u5f71\u54cd\u820c\u8c61\u5206\u7c7b\u7684\u51c6\u786e\u6027\u4ee5\u53ca\u667a\u80fd\u820c\u8c61\u8bca\u65ad\u7cfb\u7edf\u4e2d\u7684\u540e\u7eed\u8bca\u65ad\u3002\u7136\u800c\uff0c\u73b0\u6709\u7684\u820c\u8c61\u5206\u5272\u7814\u7a76\u9762\u4e34\u7740\u663e\u8457\u7684\u5c40\u9650\u6027\uff0c\u5e76\u4e14\u7f3a\u4e4f\u7a33\u5065\u4e14\u7528\u6237\u53cb\u597d\u7684\u5206\u5272\u5de5\u5177\u3002\u672c\u6587\u63d0\u51fa\u4e86\u4e00\u79cd\u57fa\u4e8e\u591a\u6559\u5e08\u77e5\u8bc6\u84b8\u998f\u7684\u820c\u8c61\u5206\u5272\u6a21\u578b\uff08TOM\uff09\u3002\u901a\u8fc7\u5f15\u5165\u4e00\u79cd\u65b0\u9896\u7684\u57fa\u4e8e\u6269\u6563\u7684\u6570\u636e\u589e\u5f3a\u65b9\u6cd5\uff0c\u6211\u4eec\u589e\u5f3a\u4e86\u5206\u5272\u6a21\u578b\u7684\u6cdb\u5316\u80fd\u529b\uff0c\u540c\u65f6\u51cf\u5c11\u4e86\u5176\u53c2\u6570\u5927\u5c0f\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u5728\u76f8\u6bd4\u6559\u5e08\u6a21\u578b\u51cf\u5c11\u4e8696.6%\u7684\u53c2\u6570\u6570\u91cf\u540e\uff0c\u5b66\u751f\u6a21\u578b\u4ecd\u7136\u5b9e\u73b0\u4e8695.22% mIoU\u7684\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684\u5206\u5272\u6027\u80fd\u3002\u6b64\u5916\uff0c\u6211\u4eec\u8fd8\u5c06\u8bad\u7ec3\u597d\u7684\u6a21\u578b\u6253\u5305\u5e76\u90e8\u7f72\u4e3a\u5728\u7ebf\u548c\u79bb\u7ebf\u5206\u5272\u5de5\u5177\uff08\u53ef\u5728https://itongue.cn/ \u8bbf\u95ee\uff09\uff0c\u5141\u8bb8\u4e2d\u533b\u4ece\u4e1a\u8005\u548c\u7814\u7a76\u4eba\u5458\u5728\u6ca1\u6709\u4efb\u4f55\u7f16\u7a0b\u7ecf\u9a8c\u7684\u60c5\u51b5\u4e0b\u4f7f\u7528\u5b83\u3002\u6211\u4eec\u8fd8\u63d0\u51fa\u4e86\u4e00\u4e2a\u4f7f\u7528\u5206\u5272\u540e\u7684\u820c\u8c61patch\u8fdb\u884c\u4e2d\u533b\u4f53\u8d28\u5206\u7c7b\u7684\u6848\u4f8b\u7814\u7a76\u3002\u5b9e\u9a8c\u7ed3\u679c\u8868\u660e\uff0c\u4f7f\u7528\u820c\u8c61patch\u8fdb\u884c\u8bad\u7ec3\u6bd4\u539f\u59cb\u820c\u8c61\u56fe\u50cf\u4ea7\u751f\u66f4\u9ad8\u7684\u5206\u7c7b\u6027\u80fd\u548c\u66f4\u597d\u7684\u53ef\u89e3\u91ca\u6027\u3002\u636e\u6211\u4eec\u6240\u77e5\uff0c\u8fd9\u662f\u7b2c\u4e00\u4e2a\u5f00\u6e90\u4e14\u514d\u8d39\u63d0\u4f9b\u7684\u820c\u8c61\u5206\u5272\u5de5\u5177\u3002"}}
{"id": "2508.15623", "pdf": "https://arxiv.org/pdf/2508.15623", "abs": "https://arxiv.org/abs/2508.15623", "authors": ["Garrik Hoyt", "Eleanor Bergren", "Gabrielle String", "Thomas McAndrew"], "title": "Beyond Traditional Surveillance: Harnessing Expert Knowledge for Public Health Forecasting", "categories": ["q-bio.PE", "cs.CY", "stat.AP"], "comment": null, "summary": "Downsizing the US public health workforce throughout 2025 amplifies potential\nrisks during public health crises. Expert judgment from public health officials\nrepresents a vital information source, distinct from traditional surveillance\ninfrastructure, that should be valued -- not discarded. Understanding how\nexpert knowledge functions under constraints is essential for understanding the\npotential impact of reduced capacity. To explore expert forecasting\ncapabilities, 114 public health officials at the 2024 CSTE workshop generated\n103 predictions plus 102 rationales of peak hospitalizations and 114\npredictions of influenza H3 versus H1 dominance in Pennsylvania for the 2024/25\nseason. We compared expert predictions to computational models and used\nrationales to analyze reasoning patterns using Latent Dirichlet Allocation.\nExperts better predicted H3 dominance and assigned lower probability to\nimplausible scenarios than models. Expert rationales drew on historical\npatterns, pathogen interactions, vaccine data, and cumulative experience.\nExpert public health knowledge constitutes a critical data source that should\nbe valued equally with traditional datasets. We recommend developing a national\ntoolkit to systematically collect and analyze expert predictions and\nrationales, treating human judgment as quantifiable data alongside surveillance\nsystems to enhance crisis response capabilities.", "AI": {"tldr": "\u4e13\u5bb6\u516c\u5171\u536b\u751f\u77e5\u8bc6\u662f\u91cd\u8981\u7684\u5371\u673a\u5e94\u5bf9\u6570\u636e\u6765\u6e90\uff0c\u5e94\u7cfb\u7edf\u5730\u6536\u96c6\u548c\u5206\u6790\u4e13\u5bb6\u9884\u6d4b\u548c\u7406\u7531\u3002", "motivation": "Downsizing the US public health workforce throughout 2025 amplifies potential risks during public health crises. Expert judgment from public health officials represents a vital information source, distinct from traditional surveillance infrastructure, that should be valued -- not discarded.", "method": "114 public health officials at the 2024 CSTE workshop generated 103 predictions plus 102 rationales of peak hospitalizations and 114 predictions of influenza H3 versus H1 dominance in Pennsylvania for the 2024/25 season. Expert predictions were compared to computational models and rationales were analyzed using Latent Dirichlet Allocation.", "result": "Experts better predicted H3 dominance and assigned lower probability to implausible scenarios than models. Expert rationales drew on historical patterns, pathogen interactions, vaccine data, and cumulative experience.", "conclusion": "Expert public health knowledge is a critical data source that should be valued equally with traditional datasets. A national toolkit should be developed to systematically collect and analyze expert predictions and rationales to enhance crisis response capabilities.", "summary_zh": "\u57282025\u5e74\u7f29\u51cf\u7f8e\u56fd\u516c\u5171\u536b\u751f\u961f\u4f0d\uff0c\u4f1a\u589e\u52a0\u516c\u5171\u536b\u751f\u5371\u673a\u671f\u95f4\u7684\u6f5c\u5728\u98ce\u9669\u3002\u516c\u5171\u536b\u751f\u5b98\u5458\u7684\u4e13\u5bb6\u5224\u65ad\u662f\u4e00\u79cd\u91cd\u8981\u7684\u4fe1\u606f\u6765\u6e90\uff0c\u5b83\u4e0d\u540c\u4e8e\u4f20\u7edf\u7684\u76d1\u6d4b\u57fa\u7840\u8bbe\u65bd\uff0c\u5e94\u8be5\u88ab\u91cd\u89c6\uff0c\u800c\u4e0d\u662f\u88ab\u629b\u5f03\u3002\u7406\u89e3\u4e13\u5bb6\u77e5\u8bc6\u5728\u7ea6\u675f\u4e0b\u5982\u4f55\u8fd0\u4f5c\uff0c\u5bf9\u4e8e\u7406\u89e3\u80fd\u529b\u4e0b\u964d\u7684\u6f5c\u5728\u5f71\u54cd\u81f3\u5173\u91cd\u8981\u3002\u4e3a\u4e86\u63a2\u7d22\u4e13\u5bb6\u7684\u9884\u6d4b\u80fd\u529b\uff0c\u57282024\u5e74CSTE\u7814\u8ba8\u4f1a\u4e0a\uff0c114\u540d\u516c\u5171\u536b\u751f\u5b98\u5458\u5bf9\u5bbe\u5915\u6cd5\u5c3c\u4e9a\u5dde2024/25\u5e74\u5ea6\u7684\u4f4f\u9662\u9ad8\u5cf0\u548cH3\u4e0eH1\u6d41\u611f\u7684\u4e3b\u5bfc\u5730\u4f4d\u8fdb\u884c\u4e86103\u6b21\u9884\u6d4b\uff0c\u5e76\u7ed9\u51fa\u4e86102\u6761\u7406\u7531\uff0c\u4ee5\u53ca114\u6b21\u9884\u6d4b\u3002\u6211\u4eec\u5c06\u4e13\u5bb6\u9884\u6d4b\u4e0e\u8ba1\u7b97\u6a21\u578b\u8fdb\u884c\u4e86\u6bd4\u8f83\uff0c\u5e76\u4f7f\u7528\u6f5c\u5728\u72c4\u5229\u514b\u96f7\u5206\u914d\u5206\u6790\u4e86\u63a8\u7406\u6a21\u5f0f\u3002\u4e13\u5bb6\u6bd4\u6a21\u578b\u66f4\u597d\u5730\u9884\u6d4b\u4e86H3\u7684\u4f18\u52bf\uff0c\u5e76\u4e14\u5bf9\u4e0d\u592a\u53ef\u80fd\u53d1\u751f\u7684\u60c5\u51b5\u8d4b\u4e88\u4e86\u8f83\u4f4e\u7684\u6982\u7387\u3002\u4e13\u5bb6\u7684\u7406\u7531\u501f\u9274\u4e86\u5386\u53f2\u6a21\u5f0f\u3001\u75c5\u539f\u4f53\u76f8\u4e92\u4f5c\u7528\u3001\u75ab\u82d7\u6570\u636e\u548c\u7d2f\u79ef\u7ecf\u9a8c\u3002\u4e13\u5bb6\u516c\u5171\u536b\u751f\u77e5\u8bc6\u6784\u6210\u4e86\u4e00\u4e2a\u5173\u952e\u7684\u6570\u636e\u6765\u6e90\uff0c\u5e94\u8be5\u4e0e\u4f20\u7edf\u6570\u636e\u96c6\u540c\u7b49\u91cd\u89c6\u3002\u6211\u4eec\u5efa\u8bae\u5f00\u53d1\u4e00\u4e2a\u56fd\u5bb6\u5de5\u5177\u5305\uff0c\u7cfb\u7edf\u5730\u6536\u96c6\u548c\u5206\u6790\u4e13\u5bb6\u9884\u6d4b\u548c\u7406\u7531\uff0c\u5c06\u4eba\u7c7b\u5224\u65ad\u4f5c\u4e3a\u53ef\u91cf\u5316\u7684\u6570\u636e\uff0c\u4e0e\u76d1\u6d4b\u7cfb\u7edf\u4e00\u8d77\uff0c\u4ee5\u63d0\u9ad8\u5371\u673a\u5e94\u5bf9\u80fd\u529b\u3002"}}
{"id": "2508.15740", "pdf": "https://arxiv.org/pdf/2508.15740", "abs": "https://arxiv.org/abs/2508.15740", "authors": ["Alyssa Yu", "Laura P. Schaposnik"], "title": "Spatial Super-Infection and Co-Infection Dynamics in Networks", "categories": ["physics.soc-ph", "nlin.AO", "nlin.PS", "q-bio.PE"], "comment": "15 pages, 9 images, comments welcomed!", "summary": "Understanding interactions between the spread of multiple pathogens during an\nepidemic is crucial to assessing the severity of infections in human\ncommunities. In this paper, we introduce two new Multiplex Bi-Virus\nReaction-Diffusion models (MBRD) on multiplex metapopulation networks: the\nsuper-infection model (MBRD-SI) and the co-infection model (MBRD-CI). These\nframeworks capture two-pathogen dynamics with spatial diffusion and\ncross-diffusion, allowing the prediction of infection clustering and\nlarge-scale spatial distributions. We establish conditions for Turing and\nTuring-Hopf instabilities in both models and provide experimental evidence of\nepidemic pattern formation. Beyond epidemiology, we discuss applications of the\nMBRD framework to information propagation, malware diffusion, and urban\ntransportation networks.", "AI": {"tldr": "\u8be5\u6587\u63d0\u51fa\u4e86\u591a\u91cdBi-Virus\u53cd\u5e94\u6269\u6563\u6a21\u578b(MBRD)\uff0c\u7528\u4e8e\u9884\u6d4b\u5177\u6709\u7a7a\u95f4\u6269\u6563\u548c\u4ea4\u53c9\u6269\u6563\u7684\u53cc\u75c5\u539f\u4f53\u52a8\u529b\u5b66\u3002", "motivation": "\u4e86\u89e3\u75ab\u60c5\u671f\u95f4\u591a\u79cd\u75c5\u539f\u4f53\u4f20\u64ad\u4e4b\u95f4\u7684\u76f8\u4e92\u4f5c\u7528\u5bf9\u4e8e\u8bc4\u4f30\u4eba\u7c7b\u793e\u533a\u611f\u67d3\u7684\u4e25\u91cd\u7a0b\u5ea6\u81f3\u5173\u91cd\u8981\u3002", "method": "\u8be5\u6587\u4ecb\u7ecd\u4e86\u4e24\u4e2a\u65b0\u7684\u591a\u91cdBi-Virus\u53cd\u5e94\u6269\u6563\u6a21\u578b(MBRD):\u8d85\u611f\u67d3\u6a21\u578b(MBRD-SI)\u548c\u5171\u611f\u67d3\u6a21\u578b(MBRD-CI)\u3002", "result": "\u8be5\u6587\u5efa\u7acb\u4e86\u4e24\u79cd\u6a21\u578b\u4e2d\u56fe\u7075\u548c\u56fe\u7075-\u970d\u666e\u4e0d\u7a33\u5b9a\u7684\u6761\u4ef6\uff0c\u5e76\u63d0\u4f9b\u4e86\u6d41\u884c\u75c5\u6a21\u5f0f\u5f62\u6210\u7684\u5b9e\u9a8c\u8bc1\u636e\u3002", "conclusion": "\u8be5\u6587\u63d0\u51fa\u4e86MBRD-SI\u548cMBRD-CI\u6a21\u578b\uff0c\u5e76\u8ba8\u8bba\u4e86MBRD\u6846\u67b6\u5728\u4fe1\u606f\u4f20\u64ad\u3001\u6076\u610f\u8f6f\u4ef6\u6269\u6563\u548c\u57ce\u5e02\u4ea4\u901a\u7f51\u7edc\u4e2d\u7684\u5e94\u7528\u3002", "summary_zh": "\u7406\u89e3\u75ab\u60c5\u671f\u95f4\u591a\u79cd\u75c5\u539f\u4f53\u4f20\u64ad\u7684\u76f8\u4e92\u4f5c\u7528\u5bf9\u4e8e\u8bc4\u4f30\u4eba\u7c7b\u793e\u533a\u611f\u67d3\u7684\u4e25\u91cd\u7a0b\u5ea6\u81f3\u5173\u91cd\u8981\u3002\u5728\u672c\u6587\u4e2d\uff0c\u6211\u4eec\u4ecb\u7ecd\u4e86\u4e24\u4e2a\u65b0\u7684\u591a\u91cdBi-Virus\u53cd\u5e94\u6269\u6563\u6a21\u578b(MBRD)\u5728\u591a\u91cd\u5143\u79cd\u7fa4\u7f51\u7edc\u4e0a\uff1a\u8d85\u611f\u67d3\u6a21\u578b(MBRD-SI)\u548c\u5171\u611f\u67d3\u6a21\u578b(MBRD-CI)\u3002\u8fd9\u4e9b\u6846\u67b6\u6355\u6349\u4e86\u5177\u6709\u7a7a\u95f4\u6269\u6563\u548c\u4ea4\u53c9\u6269\u6563\u7684\u53cc\u75c5\u539f\u4f53\u52a8\u529b\u5b66\uff0c\u5141\u8bb8\u9884\u6d4b\u611f\u67d3\u96c6\u7fa4\u548c\u5927\u89c4\u6a21\u7a7a\u95f4\u5206\u5e03\u3002\u6211\u4eec\u5efa\u7acb\u4e86\u4e24\u79cd\u6a21\u578b\u4e2d\u56fe\u7075\u548c\u56fe\u7075-\u970d\u666e\u4e0d\u7a33\u5b9a\u7684\u6761\u4ef6\uff0c\u5e76\u63d0\u4f9b\u4e86\u6d41\u884c\u75c5\u6a21\u5f0f\u5f62\u6210\u7684\u5b9e\u9a8c\u8bc1\u636e\u3002\u9664\u4e86\u6d41\u884c\u75c5\u5b66\uff0c\u6211\u4eec\u8fd8\u8ba8\u8bba\u4e86MBRD\u6846\u67b6\u5728\u4fe1\u606f\u4f20\u64ad\u3001\u6076\u610f\u8f6f\u4ef6\u6269\u6563\u548c\u57ce\u5e02\u4ea4\u901a\u7f51\u7edc\u4e2d\u7684\u5e94\u7528\u3002"}}
